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ABSTRACT 
Ying Liu 
IMPAIRED FUNCTION OF FANCONI ANEMIA TYPE C DEFICIENT 
MACROPHAGES 
Fanconi anemia (FA) is a genetic disorder characterized by bone marrow (BM) 
failure. Previous studies suggest that FA patients exhibit alterations in immunologic 
function. However, it is unclear whether the immune defects are immune cell 
autonomous or secondary to leucopenia from evolving BM failure. The aim of the current 
study was to determine whether FA type C deficient (Fancc-/-) macrophages exhibit 
impaired function and contribute to an altered inflammatory response. In this study, 
primary peritoneal macrophage function and the inflammatory response of Fancc-/- 
immune cells after in vivo intraperitoneal (IP) administration of lipopolysaccharide (LPS) 
were assessed. Fancc-/- peritoneum exhibit normal macrophage distribution at baseline. 
However, Fancc-/- macrophages exhibit reduced adhesion both on fibronectin and 
endothelial cells, impaired migration toward monocyte chemotactic protein-1 (MCP-1) 
and macrophages-colony stimulating factor (M-CSF), and altered phagocytosis of E.coli 
and ImmunoglobulinG (IgG)-labeled latex beads compared to WT. An altered F-actin 
reorganization and impaired activation of RhoA were observed in Fancc-/- macrophages. 
After single LPS injection IP, Fancc-/- mice exhibited decreased macrophage 
recruitment, reduced peripheral inflammatory monocytes and impaired myeloid colony 
formation in presence of M-CSF. Upon M-CSF stimulation, Fancc-/- BM derived 
macrophages (BMDM) showed a decreased phosphorylation of AKT and ERK compared 
to WT, leading to reduced proliferation. Collectively, these data suggest that Fancc-/- 
 vi
macrophages and subsequent defects in adhesion, migration, phagocytosis, and 
recruitment in vivo. These data also support a Fancc-/- macrophage cells autonomous 
defect predisposing to an altered inflammatory response.  
 
Laura S. Haneline M.D., Chair 
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INTRODUCTION 
I. Overview of Fanconi anemia 
A. Clinical features of FA 
Fanconi anemia (FA) was first reported by Dr. Guido Fanconi (Fanconi et al., 
1927), who described 3 siblings with short stature, skin pigmentation, and pancytopenia. 
Subsequently, FA is defined as a rare genetic disorder characterized by progressive bone 
marrow failure, developmental anomalies, and increased predisposition to malignancy 
(Alter, 2002). Although multiple systems are affected in FA, the life-threatening features 
of this disease are hematologic. Clinically, 98% of FA patients will develop 
myelodysplastic syndromes, acute myeloid leukemia or bone marrow (BM) failure by the 
age of 40 (Young and Alter, 1994). Though blood counts are usually normal at birth, the 
size of red blood cells is often large (macrocytosis) within the first decade of life. By 20 
years of age, over 50% of patients will develop pancytopenia (Young and Alter, 1994). 
The symptoms appear progressively and often lead to BM failure. The incidence of FA is 
estimated to be 1 per 350,000 live births (Verlander et al., 1995). Though FA is found in 
all ethnic groups, it is highly prevalent in two populations: Ashkenazi Jews and the 
Afrikaans of South Africa (Moustacchi et al., 1990) (Moustacchi et al.,2002). 
A key cellular feature of FA is chromosomal instability. Chromosomal breakage 
induced by DNA cross-linking agents, including mitomycin C (MMC) and 
diepoxybutane (DEB), has been exploited to study mechanisms underlying the disease 
manifestations and to confirm the clinical suspicion for FA. Indeed, DEB testing of 
peripheral blood cells is the gold-standard clinical test used to make a definitive diagnosis 
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of FA. FA cells treated with DEB exhibit marked chromosome breakage on cytogenetic 
analyses.  
The long-term treatment for FA is hematopoietic stem cell transplantation. Over 
the last two decades, the modifications to standard allogeneic stem cell transplantation 
have reduced regimen-related toxicity and increased survival . However, finding a 
suitable donor (HLA compatibility) only occurs in 30% of patients (Gluckman et al., 
1995), which obviously remains a major hurdle for treatment. Alternatively, umbilical 
cord blood offers a potential source of hematopoietic stem cells for FA patients without 
an HLA match (Broxmeyer et al., 1989). Though hematopoietic stem cell transplantation 
improves hematologic outcomes, patients are still at increased risk of developing 
malignancies including head and neck, gynecologic, and gastrointestinal cancers. 
Therefore, further pathogenetic investigations of FA are needed to improve clinical 
outcomes for patients.  
 
B. Molecular mechanisms of FA 
For the past two decades, extensive investigation has focused on elucidating the 
function of FA proteins. Current data demonstrate that FA is caused by autosomal 
recessive mutations in any of 15 FA genes (FANCA, C, D1, D2, E, F, G, I, J, L, M,N and 
O) (de Winter and Joenje, 2009; Green and Kupfer, 2009; Mace et al., 2007; 
Smogorzewska et al., 2007; Meindl et al., 2010; Vaz et al., 2010; Stoepker et al., 2011) 
or a rare X-linked recessive mutation in FANCB. FA proteins are involved in a common 
pathway which plays multiple distinct roles (Li and Stollar, 2007). Eight FA proteins (A, 
B, C, E, F, G, L, and M) form a nuclear multi-protein core complex after activation by 
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DNA damage. The FA core complex functions as an E3 ubiquitin ligase and mediates the 
monoubiquitination of FANCD2 and FANCI (Levitus et al., 2006; Dorsman et al., 2007), 
the so-called ID complex (FANCI/FANCD2) (Sims et al., 2007). The activated ID 
complex subsequently co-localizes with downstream FA proteins (FANCD1/BRCA2, 
FANCN, and FANCJ) and other DNA-repair proteins such as RAD51. Defects in one of 
the FA core complex proteins results in lack of FA core complex formation and ID 
complex monoubiquitination. 
Understanding FA pathway function in DNA damage response has received 
significant attention in recent years. However, numerous studies demonstrate that several 
FA proteins have alternate functions that are independent of DNA damage response. For 
instance, Fanconi anemia type C (FANCC) has an important role in cellular response to 
oxidative stress, which is mediated in part through altered redox regulation and ASK1 
activation (Saadatzadeh et al., 2004). Other novel investigations have shown that FANCC 
facilitates phosphorylation of STAT proteins, which has been suggested to indicate that 
FA proteins participate in cell growth arrest, cell cycle progression, and survival (Pang et 
al., 2000; Fagerlie et al., 2001; Fagerlie et al., 2004). In addition, FANCC forms a 
cytoplasmic subcomplex with FANCA, which stabilizes nucleophosmin, a protein that 
regulates centrosome duplication and genomic stability (Du et al., 2010; Grisendi et al., 
2005; Grisendi and Pandolfi, 2005). In addition, FANCC is involved in the regulation of 
telomere length (Rhee et al., 2010). Collectively, these findings indicate that FANCC 
possesses functions independent of DNA damage response. 
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C. Fanconi anemia type C (FANCC) 
FANCC is a commonly mutated FA gene, which is conserved among vertebrates 
(de Winter and Joenje, 2009; Green and Kupfer, 2009; Mace et al., 2007; Smogorzewska 
et al., 2007; Meindl et al., 2010). FANCC encodes a 63 kDa protein with no recognizable 
motifs or domains (Patel and Joenje, 2007; Wang, 2007). It is localized in both 
cytoplasmic and nuclear cellular compartments (Yamashita et al., 1994; Youssoufian, 
1994; Hoatlin et al., 1998). The biologic consequences of lacking FANCC have been 
investigated in a murine model containing homozygous disruption of the Fancc gene 
(Chen et al., 1996). This model recapitulates many aspects of the human disease 
including hypersensitivity to DNA cross-linking agents (Carreau et al., 1998; Marathi et 
al., 1996; Haneline et al., 1998; Haneline et al., 2003; Bijangi-Vishehsaraei et al., 2005; 
Rathbun et al., 1997), defects in hematopoiesis (Haneline et al., 1999; Haneline et al., 
2003), and a predisposition to malignancies (Freie et al., 2003; Rogers et al., 2004; van 
der Heijden et al., 2004; Wreesmann et al., 2007). This model is frequently used as a 
preclinical platform to examine FA hematologic disease pathogenesis in vivo. 
Specifically, several studies demonstrate that Fancc-/- BM cells display the characteristic 
hypersensitivity to MMC and DEB (Chen et al., 1996; Carreau et al., 1998; Marathi et 
al., 1996; Haneline et al., 1998; Haneline et al., 2003; Bijangi-Vishehsaraei et al., 2005). 
Fancc-/- hematopoietic stem cells (HSCs) exhibit decreased self-renewal capacity, 
impaired short- and long-term multilineage repopulating ability, and reduced survival (Li 
et al., 2007; Haneline et al., 1999; Haneline et al., 1998; Haneline et al., 2003). In 
addition, Fancc-/- progenitors are exquisitely sensitive to low doses of TNF-α, IFN-γ, 
reactive oxygen species (ROS), and other inflammatory mediators in vitro and in vivo 
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(Haneline et al., 1998; Li et al., 2004; Haneline et al., 2003; Haneline et al., 1999). 
Furthermore, long-term exposure of Fancc-/- HSCs to TNF-α causes the outgrowth of 
cytogenetically abnormal clones and predisposition to leukemic transformation after 
transplantation (Li et al., 2007). In summary, studies using the Fancc-/- murine model 
have yielded novel insights into hematopoietic disease pathogenesis in FA. Importantly, 
emerging data from FA patients and Fancc-/- mice suggest that FA patients may have 
defects in immunity as well.  
 
D. Immune defects in FA 
A growing body of literature suggests that mutations in FA genes may also impair 
the immune system, which requires intact function of differentiated hematopoietic cells 
(Hadjur and Jirik, 2003; Sejas et al., 2007; Zhang et al., 2007). A number of clinical 
studies indicate that FA patients have altered levels of circulating cytokines (Stark et al., 
1993; Bagnara et al., 1993; Rosselli et al., 1994). The most recent study from Dufour and 
colleagues demonstrated that BM mononuclear cells from FA patients overproduce TNF-
α and IFN-γ after in vitro activation (Dufour et al., 2003). In addition, it has been 
suggested that FA patients may have an increased susceptibility to a variety of pathogens 
(Fagerlie and Bagby, 2006; MacMillan et al., 2000; Dufour et al., 2003; Schultz and 
Shahidi, 1993; Rosselli et al., 1994; Sejas et al., 2007; Froom et al., 1987; Hersey et al., 
1982; Lebbe et al., 1993; Castello et al., 1998; Perussia et al., 1987; Pedersen et al., 
1977), though it is unclear whether this observation is due to a subtle immunodeficiency 
or secondary to leukopenia from evolving BM failure.  
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Studies in Fancc-/- mice provide compelling support for a primary defect in the 
innate immune response in FA. Fancc-/- mice challenged in vivo with lipopolysaccharide 
(LPS) exhibit increased systemic inflammation and death compared to controls (Sejas et 
al., 2007), though it remains unknown what cells are responsible. Limited data suggest 
that Fancc-/- macrophage function may be altered. Fancc-/- macrophages stimulated in 
vitro with IFN-γ and LPS have increased inducible nitric oxide synthase expression and 
nitrite release (Hadjur and Jirik, 2003). In addition, Vanderwerf et al. demonstrated that 
splenic macrophages from Fancc-/- mice overexpress TNF-α in response to Toll-like 
receptor 8 (TLR8) agonists, but not TLR4 agonists (Vanderwerf et al., 2009). While 
these studies show dysfunction of Fancc-/- macrophages in vitro, other important 
macrophage functions required for an intact immune response were not examined. 
Furthermore, no studies have been done to examine whether the in vivo physiologic 
function of Fancc-/- macrophages is altered. Therefore, the overall hypothesis being 
tested in this proposal is that Fancc-/- macrophages exhibit defective function 
predisposing to an altered inflammatory response.  
 
II. Monocytes/Macrophages 
A. Function and generation of macrophages 
The immunologic system is divided into two major branches: the innate immune 
system and the adaptive immune system. Innate immunity is not specific to the type of 
organism it fights and is ready to be activated upon initial infection. Macrophages are a 
major component of innate immunity. They are equipped with a broad range of pathogen 
recognition receptors (PRR) and are capable of increasing phagocytic efficiency and 
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inflammatory cytokine production after pathogen exposure (Greaves and Gordon, 2002; 
Gordon and Read, 2002; Platt et al., 2002). Macrophages identify a “danger” by detecting 
an organism’s pathogen-associated molecular patterns and endogenous signals released 
from damaged tissues via PRR. Additionally, macrophages also play essential roles in 
tissue homeostasis at steady state via clearance of apoptotic cells and cellular debris as 
well as through production of growth factors (Swirski et al., 2009; Gordon and Taylor, 
2005). Last but not least, activated macrophages initiate an acute inflammatory response 
to recruit neutrophils and natural killer cells and to facilitate the maturation, 
differentiation and migration of dendritic cells, which proceed to activate the adaptive 
immune response (Ni and O'Neill, 2001; Matzinger, 2002; Whelan et al., 2003). 
Therefore, macrophages are the unique cell type that serves as a direct link between the 
innate and adaptive immune systems.  
As professional mononuclear phagocytes, macrophages are primarily described as 
a population of long-lived myeloid cells that are derived from the BM. Like other 
hematopoietic cells, macrophages originate from HSCs, which sequentially differentiate 
into multipotent progenitors incapable of self-renewal. Successive lineage commitment 
steps during monocyte/macrophage development include common myeloid progenitor 
(CMP), granulocyte macrophage progenitor (GMP), and BM monocytes, which are 
illustrated in Figure 1(Varol et al., 2007; Iwasaki and Akashi, 2007; Geissmann et al., 
2003). CMPs are multipotent cells that generate megakaryocytes, erythrocytes, 
granulocytes and monoycte/macrophages (Chang, 2009). GMPs are more committed and 
give rise to granulocytes and macrophages only (Varol et al., 2007; Iwasaki and Akashi, 
2007). The process of lineage designation and restriction are regulated by selective and 
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gradual modulation of lineage-specific transcription factors and cytokine signaling 
pathways.  
Colony stimulating factor-1 [(CSF-1) also known as macrophage colony 
stimulating factor (M-CSF)] regulates differentiation, proliferation, and survival of the 
monocyte/macrophage lineage (Bonifer and Hume, 2008). The critical role for M-CSF in 
macrophage generation is documented in CSF-1 and CSF-1 receptor deficient mice, 
which have a reduction in several macrophage populations (Umeda et al., 1996) (Yu et 
al., 2008). As an essential growth factor for macrophage differentiation, M-CSF 
stimulates BM cells to differentiate into macrophages in vitro, bone marrow derived 
macrophages (BMDM), which serve as a powerful model system to study macrophage 
differentiation and function (Zhu et al., 2008; Ikeda et al., 2008; Uemura et al., 1993). 
  
9 
 
 
Figure 1. Simplified schematic of monocytes/macrophages generation in the BM. 
The BM consists of HSCs, which are pluripotent cells capable of self-renewal, and 
committed progenitor cells. HSCs give rise to CMP that differentiate into GMP which 
eventually mature into monocytes and macrophages. HSC: hematopoietic stem cell; 
CMP: common myeloid progenitor; GMP: granulocyte macrophage progenitor. 
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B. Innate immune response during inflammation 
Inflammation is a tightly controlled process that is initiated following tissue injury 
or infection. The synchronized action of professional phagocytes, e.g., neutrophils, 
macrophages, and monocytes, is crucial for effective elimination of intruders and cell 
debris. To initiate an inflammatory response, resident macrophages recognize pathogens 
and produce inflammatory cytokines/chemokines. Subsequently, neutrophils are recruited 
during inflammation and release a large array of granules and then become apoptotic, 
which in turn promotes monocyte influx. After removal of cellular debris, the 
inflammatory response is terminated by macrophages via release of anti-inflammatory 
mediators following ingestion of apoptotic neutrophils (Gordon and Taylor, 2005). Multi-
functional macrophages also manipulate the adaptive immune response and repair 
damaged tissues during inflammation (Gordon, 2007; Gordon and Martinez, 2010; 
Schneberger et al., 2011; Taylor et al., 2005). An illustration of a local inflammatory 
response, including leukocyte recruitment after LPS challenge, is shown in Figure 2. 
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Figure 2. Leukocyte recruitment after LPS treatment. LPS activated resident 
macrophages release inflammatory cytokines/chemokines which promote the recruitment 
of neutrophils to the inflamed site. Neutrophils release granules, which recruits 
monocytes from the peripheral blood and promotes the activation of monocytes to 
macrophages. Activated macrophages control the life-span of neutrophils by producing 
GM-CSF and are also responsible for removing apoptotic cells by phagocytosis. 
Macrophages produce anti-inflammatory cytokines and growth factors during 
phagocytosis to promote tissue-repair and leave the inflamed site from draining lymph 
nodes.
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C. The generation of monocytes/macrophages during inflammation 
During inflammation, the origination of monocytes/macrophages from the BM is 
influenced by the immunologic storm and stress (Chang, 2009). For instance, in vivo 
studies show that lipopolysaccharide (LPS) is sufficient to activate tissue resident 
macrophages to produce a large amount of inflammatory cytokines/chemokines. 
Mobilization of white cells from the BM to the peripheral blood is increased immediately 
as a result. Inflammatory monocytes are an important inflammatory cell type that is 
mobilized with subsequent migration towards local inflammatory loci. Based on Ly6C 
expression, murine monocytes can be differentiated into two discrete subpopulations: 
Ly6Chi and Ly6Clo (Yona et al., 2010; Ziegler-Heitbrock, 2007; Auffray et al., 2007; 
Nahrendorf et al., 2007). The ratio of Ly6Clo to Ly6Chi is fairly stable at steady state. 
However, following inflammation, Ly6Chi monocytes (also known as inflammatory 
monocytes) egress from the BM into the peripheral blood in a CCR2-dependent fashion 
(Tsou et al., 2007; Serbina et al., 2003; Serbina and Pamer, 2006; Geissmann et al., 
2003), which is likely determined by the inflammatory milieu and PRRs (Auffray et al., 
2009).  
In vivo studies also demonstrate that local inflammatory response is sufficient to 
induce an expansion of HSCs and progenitors in the BM as defined by the LSK 
phenotype (cells negative for lineage markers and positive for Sca1 and c-kit) (Rodriguez 
et al., 2009). HSC and progenitor expansion is primarily due to enhanced 
cytokine/chemokine production during inflammation. In addition, Nagai et al., showed 
that CMP and GMP differentiate into F4/80hi macrophages in vitro in the presence of 
LPS or pam3csk4 (a TLR2 agonist) (Abramson et al., 1977), suggesting that TLR ligands 
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directly regulate hematopoietic cell proliferation and fate determination. In summary, 
TLR activation of hematopoietic progenitors constitutes an important innate immune 
response to expand the monocyte/macrophage lineage during an infection. The 
differentiation and proliferation of monocytes/macrophages are regulated by a network of 
cytokines, chemokines, and immunological stresses (Figure 3A-B). 
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Figure 3. Life-cycle of macrophages. A) Steady state monocyte life-cycle. Monocyte 
generation from HSCs, mobilization into the peripheral blood, and extravasation into 
tissues occurs at a relatively low frequency in steady state conditions. B) Life-cycle of 
monocytes during inflammation. Monocytes in the BM are mobilized quickly after an 
inflammatory stress and migrate to locally inflamed tissues where they become activated 
macrophage. Concurrently, expansion of HSCs, CMP, and GMP occurs in the BM after 
an inflammatory stimulus. Abbreviations: HSC, hematopoietic stem cell; CMP, common 
myeloid progenitor; GMP, granulocyte macrophage progenitor.
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III. Cytoskeletal reorganization regulates macrophage function 
A. Cytoskeletal rearrangement in macrophages 
Actin cytoskeletal rearrangement is fundamental for many aspects of immune 
response to infection. For instance, adhesion, spreading of immune cells on the vascular 
endothelium, migration to the inflammatory site, and formation of phagosomes are 
dependent on proper organization of the actin cytoskeleton (Burkhardt et al., 2008; 
Fooksman et al., 2010; Batista et al., 2010; Hidalgo and Frenette, 2007; Bokoch, 2005). 
The clinical significance of active reorganization of the actin cytoskeleton in immune 
cells is accentuated by several human diseases where this process is disrupted. For 
instance, individuals with mutations in the Wiskott–Aldrich syndrome gene (WASP) 
suffer recurrent infections due to altered cytoskeletal rearrangements resulting in 
dysfunctional migration, proliferation, and survival of immune cells (Notarangelo et al., 
2008; Thrasher and Burns, 2010). Likewise, a dominant-negative mutation in the RAC2 
gene results in recurrent infections due to a cytoskeletal alteration of phagocytes 
(Williams et al., 2000).  
Several cell structures composed of F-actin including lamellipodia and filopodia 
are present in macrophages. Lamellipodia are thin, broad projections at the edge of a 
mobile cell and are dynamic structures that constantly change shape. They contain an 
extensively branched array of actin filaments, oriented with their plus ends toward the 
plasma membrane. Forward extension of a lamellipodium occurs by growth of actin 
filaments adjacent to the plasma membrane. Filopodia (microspikes) are long, thin and 
transient processes that extend out from the cell surface. They are enriched with bundles 
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of parallel actin filaments that are closely spaced and provide stiffness (DeFife et al., 
1999) . 
In fact, a successive migration of macrophages requires the synergistic 
coordination of all cytoskeletal structures described above. Specifically, the forward 
movement of a cell can be divided into several sequential steps. First is the protrusion of 
filopodia and lamellipodia, which are full of actin filaments located at the leading edge of 
a cell. Secondly, the protrusions adhere on the substratum via focal complexes. Lastly, 
the cell contracts cytoplasmic actomyosin and releases contact sites at the tail of the cell 
(Allen et al., 1998; Sheetz et al., 1999). Dynamic and integrated coordination of the actin 
cytoskeleton in macrophages has an essential role in cell movement.  
In addition to adhesion and migration having an integral role in regulating the in 
vivo trafficking of monocytes/macrophages, a major function of macrophages once in 
tissue beds is phagocytosis of cell debris, pathogens, and apoptotic cells (Savill et al., 
1989; Dockrell et al., 2001). Phagocytosis is also tightly regulated by the actin 
cytoskeleton (Yamada et al., 1989; Haberzettl et al., 2007). The phagocytic process is 
comprised of several sequential and complex events initiated by specific receptors on the 
surface of phagocytic cells. The signal generated by the receptors clustering in turn leads 
to the local polymerization of actin filaments and to particle internalization (Niedergang 
and Chavrier, 2005). Formation of phagosomes requires the assistance of local 
reorganization of the actin cytoskeleton. Although the mechanisms associated with 
ingestion are diverse according to different particles and receptors, studies have 
highlighted the significance of small GTP-binding proteins of the Rho family in 
phagocytosis (Niedergang and Chavrier, 2005). 
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B. Regulators of cytoskeletal rearrangement in macrophages 
1. Overview of Rho GTPases 
Rho GTPases belong to the Ras-like families that link signal transduction 
pathways through multiple cell-surface receptors to a variety of intracellular signaling 
proteins. Rho GTPases function as molecular switches between an inactive form (GDP-
bound) and an active form (GTP-bound) (Bar-Sagi and Hall, 2000). They are regulated 
by guanosine exchange factors (GEFs) and GTPase-activating proteins which promote 
GTP loading and accelerate GTP hydrolysis, respectively (Cerione and Zheng, 1996). 
Along with a variety of effectors, the GTP-bound Rho GTPases regulate actin 
cytoskeletal reorganization, cell shape, elongation, polarization, and motility (del Pozo et 
al., 1999; Yang et al., 2001a). To date, the best studied Rho GTPases are RhoA, Rac, and 
Cdc42. All of these small GTPases are of importance for cell shape, adhesion, motility 
and cell-cycle progression. Specifically, RhoA is essential for cell shape and adhesion by 
assembling contractile actin microfilaments into stress fibers (Hall, 1998). Formation of 
lamellipodial and filopodial protrusions are mainly dependent on Rac and Cdc42 
GTPases (Hall, 1998). In summary, the balance of Rho GTPase activities determines 
cellular morphology and migratory behavior (Evers et al., 2000).  
 
2. Role of RhoA, Rac, and Cdc42 in macrophages 
Three Rho isoforms have been identified in mammals, RhoA, RhoB and RhoC 
(Wheeler and Ridley, 2004). Macrophages only express RhoA and RhoB (Wheeler and 
Ridley, 2007), which have distinct cellular localization. RhoA is mainly in the cytosol, 
complexed to Rho GDP-dissociation inhibitors which maintain Rho GTPases as soluble 
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inactive cytosolic proteins. RhoB is mainly restricted in membranous compartments 
(Adamson et al., 1992). Macrophages expressing a RhoA dominant-negative mutant 
display impaired CR3-mediated phagocytosis and migration. Mice with conditionally 
deleted RhoA in macrophages have not been described to date. RhoB is unique among 
this subclass of small GTPases because expression is induced in response to genotoxic 
agents as well as mitogens (Fritz et al., 1999). Indeed, RhoB is required for DNA-
damage-induced apoptosis of mouse embryonic fibroblasts (Liu et al., 2001).  
The Rac subfamily of GTPase includes Rac1, Rac2, and Rac3 that share high 
homology. Macrophages lacking Rac1 are elongated but have normal migration (Wells et 
al., 2004). Macrophages expressing a Rac1 dominant-negative mutant exhibit impaired 
migration and Fc-γ-dependent phagocytosis (Jones et al., 1998; Caron and Hall, 1998). 
Similarly, Rac1/Rac2-null macrophages appear to be elongated and star-like cells with 
multiple long protrusions, but with normal migration (Wheeler et al., 2006). 
Macrophages lacking only Rac2 have a relatively normal shape, but are deprived of 
podosomes, implicating a migration defect upon contact with the extracellular matrix 
(Linder, 2007). Rac2 null mice display hematopoietic defects in formyl-methionyl-
leucyl-phenylalanine-induced migration and superoxide production, chemokine-induced 
chemotaxis, and cell survival (Yang et al., 2001a; Roberts et al., 1999; Yang et al., 2000; 
Yang et al., 2001b; Kim and Dinauer, 2001). However, in murine macrophages, studies 
have shown that Rac1 is the predominant isoform (Yamauchi et al., 2004; Pradip et al., 
2003). 
In dendritic cells and macrophages, Cdc42 is required for podosome assembly 
through WASP complex-induced actin polymerization. Indeed, the interaction with 
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WASP separates Cdc42 from Rac (Weed et al., 1998). Macrophages with Cdc42 
dominant-negative mutants exhibit disrupted polarity and reduced chemotaxis (Allen et 
al., 1998). In summary, Rho, Rac, and Cdc42 small GTPases are essential for cell shape, 
adhesion, and motility of macrophages. 
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IV. RESEARCH RATIONALE 
Although FA hematologic dysfunction is primarily considered to be a disease 
affecting the function of HSCs and progenitors, studies in both FA patients and FA gene 
murine models suggest that immune defects exist (Hadjur and Jirik, 2003; Sejas et al., 
2007; Zhang et al., 2007; Stark et al., 1993; Bagnara et al., 1993; Rosselli et al., 1994; 
Dufour et al., 2003; Fagerlie and Bagby, 2006; MacMillan et al., 2000; Schultz and 
Shahidi, 1993; Froom et al., 1987; Hersey et al., 1982; Lebbe et al., 1993; Castello et al., 
1998; Perussia et al., 1987; Pedersen et al., 1977). However, it is not clear from previous 
studies whether innate immune defects observed in FA are immune cell autonomous or 
secondary to leukopenia from evolving BM failure. Limited studies in Fancc-/- mice 
provide support for a primary defect in macrophages. Fancc-/- mice challenged in vivo 
with LPS have increased serum inflammatory mediators (Sejas et al., 2007; Vanderwerf 
et al., 2009), though it remains unknown what cells are responsible. Fancc-/- 
macrophages stimulated in vitro with IFN-γ and LPS have increased inducible nitric 
oxide synthase expression and nitrite release (Hadjur and Jirik, 2003). In addition, splenic 
macrophages from Fancc-/- mice overexpress TNF-α in response to toll-like receptor 8 
(TLR8) agonists, but not TLR4 agonists (Vanderwerf et al., 2009). While these studies 
show dysfunction of Fancc-/- macrophages in vitro, other important macrophage 
functions required for an intact immune response have not been examined. Furthermore, 
no studies have examined whether the in vivo physiologic function of Fancc-/- 
macrophages is altered. Therefore, the overall goal of these studies was to assess whether 
Fancc-/- macrophages exhibit altered function, thereby leading to an impaired 
inflammatory response in vivo. 
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V. HYPOTHESIS AND AIMS 
 
Hypothesis: Fancc-/- macrophages exhibit defective function predisposing to an 
altered inflammatory response. 
Aim 1: To examine whether Fancc-/- mice exhibit an altered inflammatory response in 
vivo. 
Aim 2: To determine whether Fancc-/- macrophages exhibit cell autonomous defects on 
adhesion, migration, and phagocytosis. 
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MATERIALS AND METHODS 
1. Mice 
Fancc-/- mice were previously described (Chen et al., 1996). Fancc+/- mice were 
intercrossed with C57BI/6J mice for more than 10 generations to develop an inbred 
strain. Since Fancc-/- mice are infertile, Fancc+/- mice were bred to generate Fancc-/- 
and WT mice. The genotype of mice was determined by PCR as described (Haneline et 
al., 1998). The following primers were used: 5’CCTGCCATCTTCAGAATTGT3’ (exon 
8 primer), 5’GAGCAACACAAATGGTAAGG3’ (intron 8 primer), and 
5’TTGAATGGAAGGATTGGAGC3’ (neomycin resistance gene primer).  
These mice were maintained under specific pathogen-free conditions in the Indiana 
University Laboratory Animal Research Center, Indianapolis, IN. All studies were 
approved by the Indiana University School of Medicine Animal Care and Use 
Committee. 
 
2. Treatment of mice and isolation of resident peritoneal cells 
Age-matched (6 to 12 weeks) WT and Fancc-/- mice were used for all 
experiments. Mice were injected intraperitoneally (IP) with either a single dose of LPS (1 
mg/kg suspended in 500 μL PBS) or a single dose of sodium periodate (5 mM, 1 mL) to 
induce inflammation (Sejas et al., 2007; Suh et al., 2006). An equal volume of the vehicle 
control (phosphate buffered saline, PBS) was used for both models. Peritoneal lavage was 
conducted with 10 mL of ice cold PBS to collect cellular exudates for in vitro analyses at 
times indicated. Peritoneal cells were washed with PBS twice and resuspended in 
Roswell Park Memorial Institute medium (RPMI) 1640 (Invitrogen, Carlsbad, CA) 
23 
 
containing 10% fetal calf serum (FCS, Lonza Walkersville, Walkersville, MD). 
Recovered peritoneal cells were diluted and counted on an electronic cell counter 
(Beckman Coulter). Each sample was counted in duplicate. Cells were then prepared for 
adhesion, migration, and flow cytometry assays. An aliquot of cells was plated with 
macrophage media (RPMI containing 10% FCS). After a 2-hour incubation at 37°C, 5% 
CO2, non-adherent cells were removed by washing with PBS, and the remaining adherent 
cells were cultured for 24 hours before conducting functional assays. For phagocytosis 
assays, fresh peritoneal cells were plated in either chamber slides (Thermo Scientific, 
Rochester, NY) for phagocytosing E.coli bioparticles or coverslips (Schott, Louisville, 
KY) for uptake of IgG latex beads.  
 
3. Differential counts of peritoneal cells 
An aliquot of recovered peritoneal cells was used to make cytospin preparations 
and for flow cytometry analyses. The cytospin slides were stained with Giemsa for 
differential counts. A representative photomicrograph is shown in Figure 4. Two hundred 
cells per slide were counted.  
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Figure 4. Differential counts of peritoneal cells. Giemsa stain of peritoneal cells after 
LPS injection. Macrophages indicated by M are large, round and heavily vacuolated 
cells. Neutrophils indicated by N are smaller cells with a fragmented nucleus.  
25 
 
4. Flow cytometry  
Resident peritoneal cells were incubated with antibodies that recognize 
macrophage antigens including CD11b or Mac1, CD115, and F4/80. Specific antibodies 
used for these studies were FITC-conjugated mouse CD11b (BD, San Diego, CA), PE-
conjugated mouse CD115 (eBioscience, San Diego, CA), and APC-conjugated mouse 
F4/80 (Invitrogen). To quantitate inflammatory monocytes, peripheral blood was 
collected from WT and Fancc-/- mice. A small aliquot was used for total white blood cell 
count determination as described (Haneline et al., 1999). The majority of sample was 
treated with ACK lysing buffer (Lonza Walkersville, Walkersville, MD) to remove red 
blood cells. The remaining cells were incubated with antibodies that distinguish 
inflammatory monocytes (Hokeness et al., 2005). Specific antibodies used for these 
studies were FITC-conjugated mouse Ly-6C (BD), PE-conjugated CD11b (BD), and 
APC-conjugated F4/80 (Invitrogen). Isotype control antibodies were used to correct 
background fluorescence and set analysis gates. Cells were acquired using a 
FACSCalibur (BD) and analyzed with CellQuest software (BD). 
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5. Myeloid colony formation assay 
WT and Fancc-/- BM low-density mononuclear cells (MNCs) were prepared and 
plated in hematopoietic progenitor assays as described with minor modifications in the 
cytokines used (Haneline et al., 1998; Haneline et al., 2003). Briefly, MNCs from the 
BM of WT and Fancc-/- mice were resuspended in Iscove modified Dulbecco medium 
(IMDM; GIBCO) supplemented with 20% FCS. Cells were plated (5 × 104 cells/mL) in 
methylcellulose (STEMCELL Technologies Inc, Vancouver, British Columbia, Canada) 
in the presence of M-CSF (50 ng/mL) and/or GM-CSF (10 ng/mL). Total colonies, 
including colony forming unit–granulocyte (CFU-G), colony forming unit–macrophage 
(CFU-M), and colony forming unit–granulocyte macrophage (CFU-GM), were scored 7 
days after plating under a light microscope. Colony morphology was used to determine 
individual hematopoietic colony type as illustrated in Figure 5. 
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Figure 5. Representative photographs of individual hematopoietic progenitor 
colony. M-CSF and GM-CSF induced colonies are mainly divided into three types – 
CFU-GM, CFU-M, and CFU-G. CFU-GMs are relatively large colonies which consist of 
more cells with various sizes. CFU-Ms are recognized as colonies with an aggregation of 
large dispersed macrophages. The smallest colonies are CFU-Gs which are comprised of 
dispersed granulocytes. 
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6. Differentiation of bone marrow derived macrophages (BMDM) 
BMDM were obtained using the conditions adapted from Racoosin and Swanson 
(Racoosin and Swanson, 1989). Total bone marrow cells flushed from mouse femurs 
were washed twice in IMDM. Total bone marrow cells from each mouse were suspended 
in 20 mL IMDM with 20% FCS, 50 ng/mL M-CSF, 1% penicillin, and 100 μg/mL 
streptomycin and plated on a single 100 mm petri dish (non-tissue culture plastic) (Day 
0). Following 12 hours at 37°C, non-adherent cells were collected and transferred to a 
new 100 mm tissue culture dish, whereas adherent cells were discarded. After 3 days of 
differentiation, non-adherent cells were collected, centrifuged, re-suspended in fresh 
differentiation media, and added back to the original tissue culture dish. On day 6 of 
differentiation, adherent cells were either collected using cold PBS for experiments or 
new media added. Day 6-8 differentiated BMDMs were used for all experiments.  
 
7. Apoptosis assay 
Apoptosis of BMDM was examined by terminal deoxynucleotidyl transferase 
(tDt)-mediated dUTP nick end-labeling (TUNEL) assay (Roche Diagnostics, 
Indianapolis, IN) (Saadatzadeh et al., 2009; Li et al., 2004). Cells were treated with 
mitomycin C (50 nM and 500 nM) as positive controls. In detail, BMDM were fixed with 
4% formaldehyde for 30 minutes at room temperature and permeabilized with 0.1% 
sodium citrate (Fisher Scientific, Fair Lawn, NJ), 0.1% Triton-X100 (Boehringer 
Mannheim, Mannheim, Germany) for 2 minutes at 4°C. Cells were incubated with Tdt 
and dUTP-FITC in a humidified environment at 37°C, 5% CO2 for 1 hour. After 
incubation, cytospins were evaluated by fluorescence microscopy. Photographs were 
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obtained of each condition and scored for apoptotic cells. A total of at least 100 cells 
from at least three independent experiments were analyzed for apoptotic cells.  
Apoptosis assay of peritoneal cells were tested by expression of annexin V (BD) 
and 7AAD (BD) in cells. Cells stain positive for both antibodies by flow cytometry are 
defined as early apoptotic cells.  
 
8. Proliferation assay 
Starved BMDM were stimulated with M-CSF (50 ng/mL) for 24 hours and pulsed 
with 0.037 MBq (1.0 µCi) of [3H]-thymidine (Amersham Biosciences, Piscataway, NJ) 
for 6 hours at 37°C prior to harvesting. The cells were washed 4 to 5 times with PBS. 
Thymidine incorporation was measured using a Beckman Coulter LS 6500 Multipurpose 
Scintillation counter (Beckman Coulter, Fullerton, CA) (Munugalavadla et al., 2005).  
 
9. Immunoblot analysis 
BMDMs and peritoneal cells were lysed and quantitated using a bicinchoninic 
acid (BCA) protein assay (Pierce Chemical, San Diego, CA). Lysis buffer includes: 0.5 
M Hepes, 5 M NaCl, 50% Glycerol, 25% Triton X, 1 M MgCl2, 250 mM EDTA, and 
Protease inhibitors and PMSF. Equal amounts of proteins were separated on a 4-12% 
sodium dodecyl sulfate (SDS)–polyacrylamide gradient gel (Invitrogen) by 
electrophoresis and transferred to nitrocellulose membranes. Membranes were blocked 
with Tris-buffered saline Tween containing 5% nonfat milk for 1 hour. For 
immunodetection of ERK and AKT, anti-ERK (phospho and total), and anti-AKT 
(phospho and total) were used at a 1:1000 dilution for 12 hours. All primary antibodies 
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were from Cell Signaling (Danvers, MA). The secondary antibody, anti-rabbit-
horesradish peroxidase (HRP) (Amersham Biosciences), was used at a 1:5000 dilution for 
1 hour before visualizing by ECL chemiluminescence. 
 
10. Adhesion assays 
Adhesion assays were performed on fibronectin (FN, recombinant human 
fragment CH296, Takara Bio Inc, Madison, WI) or on endothelial cells as described 
(Munugalavadla et al., 2005; Hollingsworth et al., 2007). For assay on FN, flat-bottom 
96-well polystyrene plates were coated with FN at a concentration of 2 μg/mL at 37°C 
for 1 hour and then washed twice. Peritoneal cells (1 × 105) were added to each well and 
allowed to adhere at 37°C for 1 hour. Unbound cells were removed by aspiration, and 
wells were washed twice with cold PBS. Adherent cells were fixed with 4% 
paraformaldehyde (Sigma, St. Louis, MO) and stained with 0.1% crystal violet (Sigma). 
Adherent cells were photographed in 5-6 random fields/well with a Leica microscope 
using a 10X objective lens. For assay on activated endothelial cells, human endothelial 
colony-forming cells (Ingram et al., 2008) were cultured in a 96-well plate to 100% 
confluence followed by treatment with LPS (1 μg/mL) or vehicle control for 24 hours. 
Carboxy-fluorescein diacetate, succinimidyl ester (CFSE, Sigma) was used to label 
peritoneal cells at a concentration of 1 μM for 8 minutes. CSFE-stained peritoneal cells (5 
× 104 cells) were added to endothelial monolayers and co-cultured for 1 and 2 hours. 
Non-adherent cells were washed off, and adherent cells were photographed in 5-6 
random fields/well with a 10X objective lens. 
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11. Transwell motility assay 
Migration assays were performed in transwell cell culture chambers with 
polycarbonate filters (24-well, 8-μm pore, corning Costar, Cambridge, MA). The filters 
were coated with FN (20 µg/mL) for 2 hours and washed with PBS. Peritoneal cells (5 × 
105 cells) in 100 µL RPMI were added to the upper chamber. RPMI (500 µL) with or 
without chemotaxis reagents (100 ng/mL M-CSF, 20 ng/mL MCP1) was placed in the 
lower chamber. After 24 hours of culture, cells remaining on the membrane in the upper 
chamber were scraped off, and cells that had migrated to the membrane in the lower 
chamber were stained with crystal violet and counted under a Leica microscope. Ten 
random fields/well were counted. 
 
12. Phagocytosis assay 
Phagocytosis was conducted with either Escherichia coli (E.coli, K-12 strain) 
bioparticles BODIPY FL conjugate (Sigma) or human serum coated latex beads (3.30 
μm, Bangs Lab, Fishers, IN). E.coli bioparticles were suspended at a concentration of 20 
mg/mL in PBS containing 2 mM sodium azide and incubated with macrophages for 1 
hour. Latex beads were incubated with human serum at a concentration of 4 mg/mL in 
PBS at 37°C for 1 hour (Suh et al., 2006). Serum coated latex beads were then re-
suspended in RPMI 1640 medium and incubated with macrophages. Phagocytosis was 
stopped by placing cells on ice and non-phagocytosed bioparticles and beads were 
washed off with cold PBS. Cells were fixed with 4% paraformaldehyde and stained with 
rhodamine phalloidin (Invitrogen) and diamidino-2-phenylindole (DAPI) (Sigma). 
Phagocytosis of E.coli was imaged using a fluorescent microscope with a 20X objective 
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lens. Ingestion of latex beads was analyzed by confocal microscopy (Olympus FV1000-
MPE confocal/multiphoton Microscope) after phalloidin staining. Images were quantified 
by counting at least 100 cells in each condition for each experiment. 
 
13. Superoxide detection 
The production of superoxide was monitored by a lucigenin chemiluminescence 
assay (Suh et al., 2006; Vazquez-Torres et al., 2000). WT and Fancc-/- peritoneal 
macrophages were plated in a 96-well flat bottom tissue culture-treated plate at a density 
of 2 × 105 cells per well (Corning Inc.) for 24 hours. After the addition of Zymosan 
particles (Invitrogen) and serum opsonized Zymosan (SOZ), cells were then incubated at 
37°C for 60 minutes in an Lma microplate luminometer. The relative amount of 
superoxide produced over 60 minutes was determined by integrating the 
chemiluminescence unit signals using a SoftMax PRO software (Molecular Devices). 
Human serum (Sigma) was used to coat Zymosan particles (Sigma) at 37°C for one hour 
to achieve SOZ.  
 
14. F-actin reorganization immunocytochemistry 
Peritoneal macrophage were adhered to glass coverslips previously coated with 
FN (2 µg/mL) for indicated times. Adherent cells were fixed with 4% paraformaldehyde 
for 10 minutes, washed with PBS, and stained with rhodamine phalloidin (100 ng/mL, 
Sigma) at 37°C for 10 minutes. The slides were washed with PBS, air dried, and mounted 
in mounting solution (DAKO, Cambridgeshire, United Kingdom). Confocal microscopic 
imaging with Olympus FV1000-MPE confocal/multiphoton equipped with an Argon 
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laser and three diode lasers were used to determine phalloidin staining. Image J was used 
to process the micrographs. Images acquired from confocal systems were opened in 
Image J and single plane images were saved as individual TIFF files only after cropping 
without any alterations. A total of at least 100 cells from at least three independent 
experiments were analyzed unless otherwise stated in the figure legend. 
 
15. GST pull-down assay for activated RhoA, Rac1 and Cdc42 
Activation of RhoA, Rac1 and Cdc42 was determined using kits from Millipore 
following the instructions provided by the manufacturer (Roberts et al., 1999). Briefly, 
WT and Fancc-/- peritoneal macrophages were harvested from 10 mice per genotype per 
experiment. Macrophages were quiesced by serum deprivation for 12 hours. Cells were 
activated by the addition of serum and then harvested at multiple time points by lysing 
with ice-cold buffer (50 mM Tris-HCl, pH 7.2, 1% TritonX-100, 0.1% SDS, 0.5% 
sodium deoxycholate, 500 mM NaCl, 10 mM MgCl2, 5 μg/mL each of leupeptin and 
aprotinin, and 1 mM PMSF). Rac1 and Cdc42 activation were analyzed by affinity 
precipitation of a GST fusion-protein corresponding to p21-binding domain (PBD 67-
150) of human PAK-1 bound to glutathione agarose (GST-PBD). RhoA-GTP was 
immunoprecipitated with a GST-tagged fusion protein, corresponding to residues 7-89 of 
mouse Rhotekin Rho Binding Domain (GST-RBD). Cell lysates were 
immunoprecipitated at 4°C for 1 hour. Immunoprecipitated complexes were subjected to 
4-12% SDS-PAGE electrophoresis. Activated Rho GTPases were detected by 
immunoblotting using antibodies against RhoA (Santa Cruz, CA), Rac1 (BD 
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Pharmingen, San Diego, CA), and Cdc42 (Santa Cruz). Blots were developed by 
enhanced chemiluminescence and bands were quantified with ImageJ software. 
 
16. RNA isolation and reverse transcription-PCR (RT-PCR) 
Total RNA from cells was isolated using RNeasy Micro Kit (QIAGEN, Valencia, 
CA). Isolated RNA was quickly evaluated by agarose gel, and RNA concentration was 
measured using a spectrophotometer. cDNA was generated by reverse transcription with 
oligo dT as a primer using the SuperScript First-Strand synthesis system (Invitrogen, 
Carlsbad, CA). The cDNA were then used as templates for PCR to detect mRNA 
expression. The RT-PCR primer sets are listed in Table 1. PCR amplification was carried 
out in a total volume of 15 μL, containing 2 μL of cDNA, 10 μL of 2X FastStart 
Universal SYBR Green Master Mix (Roche), and 0.2 μM of each primer. The PCR 
cycling conditions were 95°C for 5 minutes followed by two-step cycling 40 cycles of 
95°C for 10 seconds, and 60°C for 30 seconds. All PCR assays were performed in 
duplicate or triplicate. Fold change of gene expression was analyzed using 2-∆∆CT method 
(Livak and Schmittgen, 2001). ∆∆CT = (CT.Target - CT.Actin) Time ᵡ - (CT.Target - 
CT.Actin) Time 0. Time ᵡ is any time point and Time 0 represents the expression of the 
target gene normalized to β-actin. 
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Table 1. Primer sequences used for RT-PCR studies.  
MIP-2 Forward 5' - GAA CAA AGG CAA GGC TAA CTG - 3' 
  Reverse 5' - AAC ATA ACA ACA TCT GGG CAA T - 3' 
IL-1β Forward 5' - TCT TCT TTG GGT ATT GCT TGG - 3' 
  Reverse 5' - TGT AAT GAA AGA CGG CAC ACC - 3' 
IL-6 Forward 5' - CCA GGT AGC TAT GGT ACT CCA GAA - 3' 
  Reverse 5' - GCT ACC AAA CTG GAT ATA ATC AGG A - 3' 
MIP-1α Forward 5' - GTG GAA TCT TCC GGC TGT AG - 3' 
  Reverse 5' - TGC CCT TGC TGT TCT TCT CT - 3' 
GAPDH Forward 5' - TTT GAT GTT AGT GGG GTC TCG - 3' 
  Reverse 5' - ATC TTG TCA TCA ACG GGA AG - 3' 
KC Forward 5' - CTT GAA GGT GTT GCC CTC AG - 3' 
  Reverse 5' - TGG GGA CTA CTT TTA GCA TC - 3' 
MCP-1 Forward 5' - ACT GAA GCC AGC TCT CTC TTC CTC - 3' 
  Reverse 5' - TTC CTT CTT GGG GTC AGC ACA GAC - 3' 
TNF-α Forward 5' - AGC CCC CAG TCT GTA TCC TT - 3' 
  Reverse 5' - CTC CCT TTG CAG AAC TCA GG - 3' 
36 
 
17. Cytokine multiplex analysis of mouse serum 
Blood was collected at indicated times after LPS treatment from WT and Fancc-/- 
mice. Serum was separated by centrifugation (3,000 RPM, 10 minutes). Levels of TNF-α, 
IL-6, IL-1β, MCP-1, IFN-γ, and KC were measured using Multiplex Bead Immunoassays 
as per the manufactuer’s protocol (Millipore, Billerica, MA). A luminex 200 instrument 
(Luminex Corp, Austin, TX) was used for data acquisition and analysis. Cytokine 
concentrations were calculated using a Bio-Plex Manager 2.3 software (Bio-Rad, 
Hercules, CA) with a 5-parameter curve-fitting algorithm applied for standard curve 
calculations.  
 
18. Statistical analyses 
Parametric data are presented as mean plus or minus standard error of the mean 
(SEM), unless otherwise stated. For all data, an unpaired Student t test was conducted to 
evaluate for differences between treatment groups. A P value less than 0.05 was 
considered significant.  
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RESULTS 
AIM 1: To examine whether Fancc-/- mice exhibit an altered inflammatory 
response in vivo. To create a model of peritoneal inflammation, a low dose of LPS (1 
mg/kg suspended in 500 μL PBS) was injected into WT and Fancc-/- mice 
intraperitoneally (IP) similar to previous studies (Sejas et al., 2007; Hollingsworth et al., 
2007; Hadjur and Jirik, 2003). Figure 6 illustrates the strategy of experiments for this 
aim. In brief, after one LPS injection, serum and peritoneal cells were collected at 
indicated time points to assess the systemic and local inflammatory response in vivo. 
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Figure 6. Experimental design for Aim 1. WT and Fancc-/- mice were injected with 
LPS (1mg/mL, in 500 μL PBS) IP. To evaluate for evidence of a systemic inflammatory 
response, serum samples were collected (0-120 hours) and tested for content of 
inflammatory cytokines/chemokines by Multiplex analysis. To evaluate the local 
inflammatory response, peritoneal cells were counted, phenotyped by Giemsa staining, 
and evaluated for inflammatory gene expression by RT-PCR. 
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I. Fancc-/- mice exhibited an altered inflammatory response in vivo.  
A. Normal systemic levels of inflammatory cytokines/chemokines after LPS 
injection 
LPS administered IP induced a systemic and local response in WT and Fancc-/- 
mice. The levels of inflammatory cytokines and chemokines in the serum were measured 
by cytokine Multiplex analysis. In both genotypes, the levels of TNF-α, IL-6, and Il-1β 
showed a dramatic increase at 2 hours with a quick decline to basal levels at 12 hours 
(Figure 7). The immediate response of these inflammatory cytokines parallels the early 
recruitment of inflammatory cells to the inflamed tissue as shown by others (Lukacs et 
al., 1995). In contrast, MCP-1 levels increased at 12 hours and recovered to baseline by 
48 hours, which is consistent with the role of this chemokine in macrophage recruitment 
(Figure 7). In summary, these serum cytokines/chemokines recovered to basal levels by 
24 hours, suggesting that the LPS induced inflammatory response was controlled locally 
in the peritoneum without causing significant systemic inflammation. 
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Figure 7. Fancc-/- and WT mice had similar serum levels of inflammatory 
mediators after LPS treatment. WT and Fancc-/- mice were injected with LPS (1 
mg/kg) IP. Levels of TNF-α, IL-6, IL-1β, and MCP-1 were measured over time by 
Multiplex analysis. Six to nine mice per genotype were tested at each time point. 
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B. Local accumulation of monocytes/macrophages in LPS induced peritonitis 
Using a low dose of LPS, serum inflammatory cytokines and chemokines were 
found to be no different between WT and Fancc-/- mice, suggesting that Fancc-/- mice 
had a similar systemic inflammatory response to LPS as WT mice. We subsequently 
questioned whether Fancc-/- mice exhibit an altered local inflammatory response to LPS 
in the inflamed peritoneum. LPS injection induced a time-dependent accumulation of 
leukocytes in the peritoneum. Giesma staining of peritoneal cells from WT mice 
demonstrated the normal kinetics of leukocyte influx after LPS induced peritonitis 
(Figure 8A). After LPS induced peritoneal inflammation, neutrophil recruitment 
increased quickly. The total number of peritoneal neutrophils peaked at 24 hours and 
dropped to low levels by 72 hours (Figure 8B). Interestingly, Fancc-/- mice exhibited a 
slightly higher number of neutrophils compared to WT mice (Figure 8B). As described in 
the background, the number of neutrophils in the inflamed site is largely influenced by 
the rate of recruitment from the peripheral blood and the rate of elimination via apoptosis 
and subsequent phagocytosis by macrophage. Therefore, we hypothesized that increased 
neutrophils in the inflamed peritoneum of Fancc-/- mice may be due to increased 
neutrophil recruitment or reduced neutrophil apoptosis. Since Fancc-/- neutrophils 
exhibit impaired granulocyte colony-stimulating factor induced mobilization from the 
BM (Pulliam et al., 2008), the possibility that neutrophil recruitment was enhanced 
seemed less likely. Thus, we subsequently examined the apoptosis of peritoneal cells at 
indicated time points after LPS injection. The data showed that Fancc-/- cells had a lower 
percentage of apoptotic cells compared to WT at 24 hours (Figure 8C), a time point when 
>75% of peritoneal cells are neutrophils. These data support the hypothesis that reduced 
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neutrophil apoptosis may contribute to the increased number of neutrophils observed in 
the peritoneum of Fancc-/- mice after LPS treatment. These data also suggest that  
Fancc-/- neutrophils may exhibit autonomous defects that alter the inflammatory 
response in vivo. 
As expected, LPS induced peritonitis caused an influx of monocytes/macrophages 
into the peritoneum at later time points. In WT mice, LPS caused a significant 
extravasation of monocytes/macrophages into the peritoneal cavity, peaking at 96 hours 
and declining sharply to near basal levels by 120 hours, similar to previous studies 
(Figure 8D) (Ajuebor et al., 1999; Takahashi et al., 2009; Parsons et al., 2007; Mortier et 
al., 2005). Fancc-/- mice displayed similar kinetics for monocyte/macrophage 
recruitment after LPS injection (Figure 8D). However, the number of 
monoyctes/macrophages was significantly lower in Fancc-/- mice compared to WT in the 
later phase of inflammation (i.e. 72 to 120 hours). These data are intriguing given that 
Fancc-/- mice had more neutrophils in the peritoneum after LPS treatment, which should 
correlate with increased macrophage recruitment. We speculate that intrinsic defects in 
monocytes/macrophages may account for this observation.  
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Figure 8. Fancc-/- mice had altered number of leukocytes in LPS inflamed 
peritoneal cavity. (A) Leukocyte distribution in LPS inflamed peritoneum. At baseline 
and after LPS injection, peritoneal cells were harvested (0-72 hours) and stained with 
Giemsa for morphologic evaluation of peritoneal leukocyte distribution. Representative 
photomicrographs of peritoneal cells from WT mice are shown (M: macrophage, N: 
neutrophil). (B) Total number of peritoneal neutrophils. Neutrophil number was obtained 
by multiplying total peritoneal cells by the neutrophil percentage determined by Giemsa 
staining. Six to twelve mice per genotype were used in each of the three independent 
experiments, *P<0.05. (C) Total number of monocytes/macrophages. 
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Monocyte/macrophage number was calculated by multiplying total peritoneal cells by the 
monocyte/macrophage percentage determined by Giemsa staining. Six to twelve mice per 
genotype were used in each of the three independent experiments, *P<0.05. (D) 
Apoptosis of peritoneal cells after LPS treatment. Apoptosis was evaluated by flow 
cytometry. Cells staining positively for both annexinV and 7AAD were scored as 
apoptotic cells. Three mice per genotype were used in each of the three independent 
experiments, *P<0.05. 
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C. Accumulation of monocytes/macrophages in sodium periodate induced 
inflammatory response 
To further evaluate whether loss of Fancc alters monocyte/macrophage 
accumulation to sites of inflammation, WT and Fancc-/- mice were injected IP with 
sodium periodate as a second inflammatory stimulus, similar to previous studies 
(Yamauchi et al., 2004; Suh et al., 2006). Previous reports demonstrate that the number 
of monocytes/macrophages in the peritoneum after sodium periodate injection peaks at 
96 hours (Suh et al., 2006). Thus, we used this time point to examine whether Fancc-/- 
mice had impaired monocyte/macrophage recruitment in response to sodium periodate. 
Fancc-/- mice had fewer peritoneal macrophages demonstrated by decreased peritoneal 
exudate cellularity and decreased absolute number of Mac1+ and F4/80+ cells compared 
to WT mice (Figure 9A-B). Together these data support the hypothesis that macrophage 
accumulation is impaired in Fancc-/- mice during inflammation.  
Given the numerous roles that macrophages have in responding to and resolving 
inflammation together with the complex life cycle of monocytes/macrophages, several 
potential mechanisms could account for the observed reduction of Fancc-/- peritoneal 
macrophages after LPS induced inflammation. In the early phase of inflammation, 
Fancc-/- resident macrophages and neutrophils may release altered levels of 
inflammatory cytokines/chemokines, which would result in decreased recruitment of 
monocytes to the inflamed site. In addition, the number of inflammatory monocytes, 
which are the precursors of peritoneum macrophages, may be reduced in Fancc-/- mice. 
In the later phases of inflammation, BM expansion of monocytes/macrophages may be 
reduced in Fancc-/- mice due to impaired HSC and progenitor responsiveness to 
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inflammatory stimuli. The next series of experiments were designed to test each of these 
possibilities.  
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Figure 9. Fancc-/- mice exhibit impaired monocyte/macrophage accumulation in 
sodium periodate induced peritonitis. Peritoneal cells were harvested 96 hours after IP 
injection of sodium periodate. (A) Total peritoneal cell number is shown. Eight mice per 
genotype were used in each of the three independent experiments, *P<0.05. (B) The 
absolute number of peritoneal cells expressing macrophage antigens, Mac1 or F4/80, is 
shown. The absolute number of Mac1+ or F4/80+ is calculated by multiplying the total 
cell number by percentage of Mac1+ or F4/80+ cells determined by flow cytometry. Six 
mice per genotype were used in each of the three independent experiments, *P<0.05. 
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1. Reduced levels of inflammatory cytokines/chemokines in the early phase of 
inflammation 
Because accumulation of leukocytes in the inflamed site is largely regulated by 
cytokine/chemokine production, gene expression of multiple inflammatory mediators was 
assessed in local peritoneal cells. Initially, gene expression was examined in peritoneal 
cells at baseline and 2 hours after LPS treatment because resident macrophage account 
for the majority of cells in the peritoneum at these time points (see Figure 8). No 
differences were detected between WT and Fancc-/- peritoneal cells in the baseline 
mRNA expression of cytokines/chemokines tested. In both WT and Fancc-/-peritoneal 
cells, most transcripts of inflammatory cytokines/chemokines had a significant increase 
after LPS treatment compared to PBS controls (Figure 10A). Among them, KC had a 
dramatic increase, consistent with the role that KC serves as a neutrophil chemoattractant. 
Surprisingly, compared to WT, Fancc-/- peritoneal cells displayed a significant decrease 
in mRNA expression of TNF-α, KC, MIP-1α, and MIP-2, with a similar trend for IL-6, 
IL-1β, and MCP-1. To determine whether the reduced expression of inflammatory 
cytokines/chemokines was either impaired or delayed, we assessed expression in 
peritoneal cells at later time points (0-120 hours) (Figure 10B).These studies showed that 
Fancc-/- peritoneal cells exhibited reduced inflammatory gene expression at multiple 
time points, implying an altered inflammatory response in vivo. Additionally, we noticed 
that KC, IL-6, TNF-α, and MIP-1α exhibit different kinetics of expression patterns after 
LPS injection in both WT and Fancc-/- mice. KC expression peaked at 2 hours when 
resident macrophages were the majority cell type, indicating resident macrophages are 
important for neutrophil recruitment during inflammation. TNF-α and MIP-1α peaked at 
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24 hours when half of the peritoneal cells were neutrophils, suggesting that neutrophils 
contribute to monocyte recruitment in LPS induced peritonitis. 
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Figure 10. Fancc-/- peritoneal cells exhibited a significant decrease in gene 
expression of multiple inflammatory cytokines/chemokines after LPS treatment. 
Transcripts of inflammatory cytokines/chemokines were examined in peritoneal cells by 
RT-PCR over multiple time points. (A) Inflammatory gene expression of peritoneal cells 
2 hours after LPS treatment. Fold change in transcripts relative to WT PBS control is 
shown. Six mice per genotype were used per genotype, *P<0.05. (B) Inflammatory gene 
expression over time in peritoneal cells after LPS treatment. Fold change in transcripts 
relative to WT PBS control is shown. Six mice per genotype were used per genotype, 
*P<0.05.
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2. Decreased inflammatory monocytes in Fancc-/- mice 
a. Inflammatory monocytes in the peripheral blood 
Given the observation that Fancc-/- peritoneal cells had reduced expression of 
chemokines required for monocyte recruitment, we speculated that Fancc-/- mice may 
have fewer circulating monocytes in the peripheral blood after LPS treatment. 
Inflammatory monocytes, defined as Mac-1+F4/80+Ly-6Chigh cells, are mobilized from 
the BM into the peripheral blood and specifically recruited to inflamed tissue sites (Crane 
et al., 2009; Geissmann et al., 2003; Gordon and Taylor, 2005; Sunderkotter et al., 2004; 
Tacke and Randolph, 2006). Therefore, we examined whether Fancc-/- mice had reduced 
circulating inflammatory monocytes after LPS treatment. Figure 11A illustrates the 
gating strategy for flow cytometry studies. By 24 hours, WT and Fancc-/- mice exhibited 
an increase in the percentage and total number of Mac-1+F4/80+Ly-6Chigh cells in the 
peripheral blood compared to controls (Figure 11B-C). However, Fancc-/- mice had 
fewer circulating Mac-1+F4/80+Ly-6Chigh cells compared to WT mice. By 48 hours, 
circulating Mac-1+F4/80+Ly-6Chigh cells recovered to near baseline levels.  
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Figure 11. Fancc-/- mice exhibited decreased inflammatory monocytes in the 
peripheral blood. (A) Multiparameter flow cytometry to identify inflammatory 
monocytes. Gating strategy for flow cytometry studies is shown. Inflammatory 
monocytes were defined as Mac1+F4/80+Ly-6C high cells. M1 gate represents high 
expression of Ly-6C. (B) Percentage of inflammatory monocytes in the peripheral blood. 
The percentage of Mac1+F4/80+Ly-6C high cells determined by flow cytometry is shown. 
Three mice per genotype were used for each independent experiment, *P<0.05. (C) 
Frequency of inflammatory monocytes in the peripheral blood. Total Mac1+F4/80+Ly-6C 
high cells/mL of blood is shown. Total white blood cells were counted using a Hemavet. 
Mac1+F4/80+Ly-6C high cells were calculated by multiplying the frequency determined by 
flow cytometry with the total white blood cell count/mL of blood. Three mice per 
genotype were used for each independent experiment, *P<0.05. 
53 
 
b. Inflammatory monocytes in the BM 
Because inflammatory monocytes are mobilized from the BM during 
inflammation, we subsequently evaluated the BM for Mac-1+F4/80+Ly-6Chigh cells after 
LPS injection. These studies demonstrated that no dramatic changes were observed 
within the BM of mice from either genotype (Figure 12). By 48 hours, Fancc-/- BM cells 
had a slightly higher percentage of inflammatory monocytes compared to WT, though the 
absolute number of inflammatory monocytes in a femur was not different between 
genotypes. Collectively, these data suggest that defective monocyte mobilization from the 
BM into the peripheral blood or impaired monocyte activation to an inflammatory 
phenotype may occur in Fancc-/- mice during inflammatory stress. However, further 
studies need to be done to understand the underlying mechanisms. 
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Figure 12. Fancc-/- mice exhibited no significant alterations in the number of BM 
inflammatory monocytes. BM cells were collected at indicated time points after LPS 
injection. Inflammatory monocytes were defined as Mac1+F4/80+Ly-6C high cells. (A) 
Percentage of inflammatory monocytes in the BM. The percentage of Mac1+F4/80+Ly-6C 
high cells determined by flow cytometry is shown. Three mice per genotype were used for 
each independent experiment, *P<0.05. (B) Absolute number of inflammatory monocytes 
per femur. Total Mac1+F4/80+Ly-6C high cells/femur is shown. Three mice per genotype 
were used for each independent experiment, *P<0.05. 
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3. Reduced monocyte progenitors in the BM 
a. BM cellularity after LPS treatment 
During inflammation, leukocytes are quickly mobilized from the BM into the 
peripheral blood. Concurrently, hematopoietic stem and progenitor cells are stimulated to 
promote enhanced production of mature myeloid cells to protect from ongoing 
inflammation and to replenish the BM cell pool of leukocytes. We hypothesized that 
Fancc-/- BM cells may exhibit altered inflammation induced expansion of HSCs and 
progenitors. Therefore, we examined whether total BM cellularity was altered in Fancc-/- 
mice after LPS treatment. Femur cellularity was used as a surrogate measure of total BM 
cellularity because it is easily accessible and should be representative of other BM 
environments. Total BM cells from one femur were collected and counted from mice 
treated with LPS and compared to baseline controls. A decrease in femur cellularity was 
observed in mice from both genotypes at 24 and 48 hours compared to baseline controls 
(Figure 13). Interestingly, femur cellularity recovered to near baseline levels by 72 hours. 
However, no significant differences were observed between WT and Fancc-/- mice. The 
rapid decline in BM cellularity is consistent with mobilization of mature cells from the 
BM into the peripheral blood. By 72 hours, the recovery of BM cell number to basal 
levels suggests that hematopoietic stem and progenitor cells responded to the 
inflammatory stress via differentiation and proliferation to replenish the BM of 
differentiated leukocyte populations. 
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Figure 13. Fancc-/- mice had normal BM cellularity after LPS injection. Total BM 
cells from one femur were collected and counted from WT and Fancc-/- mice treated 
with LPS and untreated controls. Mice were sacrificed 24, 48, and 72 hours following 
LPS treatment. Six mice per genotype were used for three independent experiments, 
*P<0.05 compared to time 0. 
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b. Phenotypic characterization of monocyte progenitors in the BM after LPS 
treatment 
Previous data from our laboratory demonstrate that Fancc-/- HSC and myeloid 
progenitors exhibit defective function (Haneline et al., 1999; Haneline et al., 1998; 
Saadatzadeh et al., 2004; Saadatzadeh et al., 2009; Haneline et al., 2006; Haneline et al., 
2003). Therefore, we hypothesized that Fancc-/- myeloid progenitors may inadequately 
expand in response to inflammatory stimuli. As described in the background (Figure 1), 
the BM HSCs give rise to CMP that differentiate into GMP which eventually mature into 
monocytes and macrophages. Thus, we next questioned whether Fancc-/- BM cells 
exhibit altered myeloid population during LPS induced inflammatory response. 
Phenotypically-defined populations including LSK (Lin-Sca-1+c-Kit+) which is enriched 
with stem cells, CMP (LKS- Fc-γRloCD34+IL-7R-) and GMP (LKS- Fc-γR+CD34+IL-7R-) 
were examined by multiparameter flow cytometry. Both WT and Fancc-/- BM had an 
increase in the absolute number of LSK cells by 24 hours, and recovered to steady state 
levels by 72 hours (Figure 14). The number of CMP and GMP population, on the other 
hand, showed a dramatic increase at 72 hours, suggesting that the expansion of CMP and 
GMP takes about three days after LPS treatment. However, no significant differences 
were observed between WT and Fancc-/- mice. 
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Figure 14. Phenotypically-defined progenitors from Fancc-/- mice exhibited normal 
LPS-induced expansion. Total BM cells from one femur were counted from control and 
LPS treated WT and Fancc-/- mice. BM cells were labeled with antibodies for the 
measurement of LSK, CMP, and GMP by multi parameter flow cytometry. Absolute 
numbers were calculated by multiplying percentage of each cell population determined 
by flow cytometry by femur cellularity. LSK was defined as lin-sca1+c-kit+. CMP was 
defined as LKS- Fc-γRloCD34+IL-7R-. GMP was defined as LKS- Fc-γR+CD34+IL-7R-. 
Six mice per genotype were used in three independent experiments.   
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c. Functional analysis of BM progenitors after LPS treatment 
Since quantitative analyses of hematopoietic stem/progenitor cell populations by 
flow cytometry were not altered in Fancc-/- mice treated with LPS, we next questioned 
whether functional impairments existed in Fancc-/- myeloid progenitors by examining 
colony forming ability in response to monocyte/macrophage growth factors BM 
mononuclear cells from LPS treated mice were cultured in methylcellulose with M-CSF 
and /or GM-CSF and assessed for the growth of myeloid progenitors after 7 days of 
culture. Because the expansion of myeloid progenitors needs time to occur after an 
inflammatory stress, we collected BM cells 48 hours after LPS injection. At this time 
point, BM cells from WT mice displayed an increase in the total number of colonies 
formed in the presence of M-CSF, GM-CSF, and M-CSF+GM-CSF compared to baseline 
levels (Figure 15). In contrast, no expansion of myeloid progenitors was observed in 
Fancc-/- BM. By 72 hours, the differences in colony formation between WT and  
Fancc-/- BM cells persisted only in conditions that included M-CSF. These data suggest 
the reduced number of colonies from Fancc-/- mice was influenced most by M-CSF. To 
determine whether specific myeloid progenitor populations were affected in Fancc-/- 
mice, colonies were scored based on morphology as CFU-GM, CFU-M, and CFU-G 
(Figure 16). As expected, the majority of colonies grown in the presence of M-CSF were 
CFU-M and CFU-GM. In M-CSF cultures, Fancc-/- BM cells had a significant reduction 
in CFU-M colonies at 48 and 72 hours after LPS treatment compared to WT. CFU-GM 
colonies were rarely observed in M-CSF cultures. In the presence of GM-CSF, with or 
without M-CSF, CFU-GM colonies were the major colony type observed from both WT 
and Fancc-/- BM cells. However, fewer CFU-GM were noted from Fancc-/- BM cells 
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collected 48 hours after LPS treatment compared to WT. Together these data indicate that 
Fancc-/- mice are capable of preserving normal phenotypic distributions of hematopoietic 
stem/progenitor cells after in vivo LPS exposure. However, in vivo LPS treatment 
significantly impairs the responsiveness of Fancc-/- myeloid progenitors to growth 
promoting cytokines, especially M-CSF.   
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Figure 15. Fancc-/- progenitors exhibited impaired colony forming ability after in 
vivo LPS exposure. BM cells were collected from untreated and LPS treated mice and 
were cultured in methylcellulose (50,000/dish) in the presence of M-CSF (50 ng/mL), 
GM-CSF (10 ng/mL), or M-CSF and GM-CSF for 7 days. Colonies were scored under an 
Olympus microscope with a 4X objective lens. Total colonies per femur were calculated 
by multiplying femur cellularity with the number of colonies scored per 50,000 BM cells 
plated. Three mice were used for each of the three independent experiments, *P<0.05 
compared to time 0, **P<0.05 compared to WT. 
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Figure 16. Fancc-/- progenitors exhibited altered distribution after in vivo LPS 
treatment. BM cells were collected from untreated and LPS treated mice and were 
cultured in methylcellulose in the presence of M-CSF (50 ng/mL), GM-CSF (10 ng/mL), 
or M-CSF and GM-CSF for 7 days. Colonies were differentially scored by morphology 
as CFU-M, CFU-G, and CFU-GM. Colony type frequencies are shown. Three mice were 
used for each of the three independent experiments, *P<0.05. 
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II. Fancc-/- BM cells exhibited an impaired response to M-CSF in vitro 
A. Decreased number of BMDM in the presence of M-CSF 
Given our data demonstrating impaired colony formation in the presence of M-
CSF together with the central role that M-CSF has in monocyte/macrophage 
differentiation, we tested whether Fancc-/- BM cells exhibited impaired M-CSF induced 
differentiation using a well-established model of macrophage differentiation in vitro, 
bone marrow derived macrophages or BMDM. For these studies, BM cells were cultured 
with M-CSF for 6 days to establish BMDM. BMDM were counted and tested for 
macrophage purity by evaluating co-expression of Mac1 and F4/80. Nearly 90% of WT 
and Fancc-/- BMDM were Mac1+ F4/80+ (Figure 17A), suggesting that Fancc-/- BM 
cells exhibit normal M-CSF induced macrophage differentiation in vitro. However, 
Fancc-/- BMDM had a significant reduction in cell number compared to WT (Figure 
17B).  
 
B. Reduced M-CSF stimulated proliferation 
The decreased number of BMDM from Fancc-/- BM cells was speculated to 
either be caused by reduced proliferation or decreased survival induced by M-CSF. To 
examine whether Fancc-/- BM cells exhibited reduced proliferation, H3 thymidine 
incorporation assays were conducted on BMDM stimulated with or without M-CSF. 
Upon M-CSF stimulation, WT and Fancc-/- cells had increased proliferation (Figure 
17C). However, a significant decrease was observed in Fancc-/- BMDM compared to 
WT, indicating that altered proliferation contributes to the observed reduction in the 
number of Fancc-/- BMDM. To evaluate whether Fancc-/- BM cells had decreased 
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survival in response to M-CSF, TUNEL assays were conducted to measure apoptosis. 
WT and Fancc-/- BMDM exhibited very low rates of apoptosis (<2%). Together, these 
data suggest that the major factor contributing to decreased BMDM cell number is 
impaired M-CSF induced proliferation and not a survival defect. 
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Figure 17. Fancc-/- BM cells exhibited reduced proliferation in response to M-CSF. 
BM mononuclear cells were cultured in the presence of M-CSF (50 ng/mL) for 6 days to 
establish BMDM. (A) Phenotypic analysis. A representative dot plot illustrating Mac1 
and F4/80 expression is shown. (B) BMDM cellularity. The number of viable cells is 
shown. Six independent experiments were performed, *P<0.05. (C) Proliferation assays. 
Thymidine incorporation assays were used to evaluate proliferation of BMDM at baseline 
and after M-CSF stimulation (50 ng/mL for 24 hours). Six independent experiments were 
performed, *P<0.05, compared to WT, **P<0.05, compared to no M-CSF. 
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C. Impaired phosphorylation of ERK and AKT upon M-CSF stimulation 
ERK and AKT activation are the major downstream targets of M-CSF signaling 
that regulate the proliferation of BMDM (Pixley and Stanley, 2004). Therefore, we next 
examined whether Fancc-/- BMDM exhibited altered phosphorylation of ERK and AKT. 
BMDM established from WT mice exhibited robust phosphorylation of ERK and AKT 
after M-CSF stimulation (Figure 18A-B). In contrast, Fancc-/- BMDM had reduced 
phosphorylation of ERK and AKT (Figure 18A-C). To ensure that differences detected in 
ERK and AKT phosphorylation were not due to impaired expression of the M-CSF 
receptor or C-Fms (CD115), flow cytometric analysis of CD115 on BMDM was 
conducted. Fancc-/- BMDM had similar expression levels of the M-CSF receptor 
compared to WT (Figure 18D). Collectively, these data indicate that Fancc-/- BMDM 
have altered M-CSF induced ERK and AKT phosphorylation which likely contributes to 
the proliferation defect observed. 
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Figure 18. Fancc-/- BMDM exhibited impaired phosphorylation of ERK and AKT 
after M-CSF stimulation. WT and Fancc-/- BMDM were either untreated or stimulated 
with M-CSF (50 ng/mL) for 15 minutes. Representative western blots of (A) 
phosphorylated ERK/total ERK and (B) phosphorylated AKT/total AKT are shown. (C) 
Densitometry analysis. Quantified data show the level of phosphorylation of ERK and 
AKT in Fancc-/- BMDM compared to WT. Three independent experiments were 
conducted,*P<0.05. (D) M-CSF receptor expression. WT and Fancc-/- BMDM were 
stained with anti-CD115-PE conjugated and evaluated by flow cytometry. The mean 
percentage of cells expressing CD115 is shown. Three independent experiments were 
performed, *P<0.05. 
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SUMMARY OF AIM 1: 
In the peritoneum after LPS induced peritonitis, Fancc-/- mice had increased 
neutrophils in early inflammatory stages and fewer monocytes/macrophages in later 
phases of inflammation. The inflammatory gene expression of Fancc-/- peritoneal cells 
was reduced, which was associated with fewer circulating inflammatory monocytes in the 
peripheral blood of Fancc-/- mice. In addition, Fancc-/- mice were capable of preserving 
normal phenotypic distributions of hematopoietic stem/progenitor cells after in vivo LPS 
exposure, however Fancc-/- myeloid progenitor responsiveness to M-CSF was 
significantly impaired. Studies using an in vitro BMDM model showed that Fancc-/- 
BMDM had reduced M-CSF induced proliferation and decreased phosphorylation of 
ERK and AKT. Overall, these observations indicate that Fancc-/- mice have an altered 
LPS induced inflammatory response and impaired M-CSF signaling. However, the 
question of whether Fancc-/- macrophages exhibit autonomous defects in function that 
contributes to the in vivo phenotype remains. 
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AIM 2: To determine whether Fancc-/- macrophages exhibit cell autonomous 
defects in adhesion, migration and phagocytosis. 
Macrophage motility is essential for normal development and immune function. 
We questioned whether Fancc-/- peritoneal macrophages have impaired cell motility 
including adhesion and migration as well as phagocytosis since this is a critical cellular 
function for macrophages. The experimental design is illustrated in Figure 19. In brief, 
peritoneal macrophages were collected and assessed for adhesion on FN and endothelial 
cells, migration toward MCP-1 and M-CSF, and phagocytosis of E.coli particles and IgG 
latex beads. These analyses were instrumental to determine whether Fancc-/- 
macrophages exhibit intrinsic alterations in function. These studies also help to clarify 
whether reduced monocyte/macrophage in the local inflamed site is due to impaired 
motility of Fancc-/- cells.   
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Figure 19. Experimental strategy for Aim 2. Peritoneal cells from age-matched WT 
and Fancc-/- mice were assessed for macrophage distribution at baseline. Three types of 
functional assays were evaluated on these peritoneal macrophages. For adhesion assays, 
peritoneal cells were allowed to adhere on either FN or endothelial cells treated with or 
without LPS (1 μg/mL). For migration assays, MCP-1 and M-CSF were chosen for the 
chemoattractant of macrophages. For phagoyctosis assays, peritoneal cells were adhered 
overnight. Adherent peritoneal macrophages were cultured with either E.coli bioparticles 
or IgG latex beads. All of these assays were measured by microscopy (bright field or 
fluorescent as indicated). 
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III. Impaired motility and function of Fancc-/- monocytes/macrophages 
A. Characterization of Fancc-/- peritoneal cells at the steady state 
Before examining whether Fancc-/- peritoneal macrophages exhibit altered 
function, the steady-state distribution of macrophages in the peritoneal cavity was 
examined. At baseline, Giemsa staining of peritoneal cells indicated that the majority of 
cells in the peritoneum were macrophages, accounting for nearly 80% of cells, and no 
differences were detected between WT and Fancc-/- mice (Figure 20A-B). Flow 
cytometric analyses of peritoneal cells from WT and Fancc-/- mice showed a similar 
phenotypic expression of macrophage antigens (Figure 20C) In addition, the absolute 
number of these phenotypically-defined cells were also similar between both genotypes 
(Figure 21D). These data demonstrate the distribution of monocyte/macrophage at steady 
state is normal in Fancc-/- mice compared to WT. 
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Figure 20. Fancc-/- peritoneum exhibited a normal leukocyte distribution. (A) 
Giemsa staining of peritoneal cells. Representative photomicrograph of peritoneal cells 
from a WT mouse is shown. Arrows indicate peritoneal monocytes/macrophages. (B) 
Differential counts determined by morphology after Giemsa staining. Six mice per 
genotype were tested in each experiment. (C) Expression of macrophage antigens in 
peritoneal cells. Peritoneal cells were evaluated for the expression of macrophage 
antigens including Mac1+, CD115+ and F4/80+. Three mice per genotype were tested in 
each experiment. (D) Absolute number of Mac1+, CD115+ and F4/80+ cells was 
calculated by multiplying total peritoneal cells by the percentage of each cell population 
determined by flow cytometry. Three mice per genotype were tested in each experiment. 
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B. Impaired adhesion of Fancc-/- peritoneal macrophages 
1. Impaired adhesion on FN 
As professional phagocytes, monocytes/macrophages are recruited to the inflamed 
site to effectively eliminate intruders and cell debris. Our data demonstrate that Fancc-/- 
mice exhibit significantly reduced monocytes/macrophages in LPS induced peritonitis. 
However, it is not clear whether this observation is due to cell autonomous defects in 
Fancc-/- macrophages. To examine whether Fancc-/- macrophages exhibit cell 
autonomous defects that contribute to the impaired accumulation in vivo, we next 
examined whether Fancc-/- macrophages have altered adhesion and migration. To 
evaluate whether adhesion of Fancc-/- macrophages is compromised, resident 
macrophages were adhered to either FN, which is an important component of the 
extracellular matrix, or to endothelial cells, which represents a physiologically-relevant 
cell type. For adhesion to FN, fewer Fancc-/- macrophages adhered to FN after 1 hour 
compared to WT (Figure 21A-B).   
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Figure 21. Fancc-/- macrophages exhibited reduced adhesion on FN. Fresh peritoneal 
cells were collected from WT and Fancc-/- mice in the steady state. Cells were allowed 
to adhere on FN (CH296) coated and uncoated wells for one hour. Nonadherent cells 
were removed by washing with PBS. Adherent cells were estimated after Giemsa 
staining. Photomicrographs were taken on a Leica microscope (20X). (A) Representative 
photomicrographs are shown. (B) Quantitative data of levels of adhesion for Fancc-/- 
cells compared to WT are shown. Three independent experiments were 
performed,*P<0.05.
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2. Impaired adhesion on endothelial cells 
Given that circulating leukocytes are recruited to the inflamed endothelium, 
where they adhere and traverse between endothelial cells to enter the inflammatory site 
(Kubes, 2002), we next questioned whether cell-cell adhesion was also altered in  
Fancc-/- macrophages by conducting macrophage-endothelial cell co-culture assays. In 
addition to conducting assays under baseline conditions, endothelial cells were stimulated 
with LPS (1 μg/mL) prior to co-culture with macrophages to model the upregulation of 
adhesion molecules that occurs on endothelial cells during inflammation (Lush et al., 
2000). In conditions with untreated endothelial cells, WT macrophages had increased 
adherence after 2 hours of co-culture compared to the 1 hour time point (Figure 22A-B). 
In contrast, Fancc-/- macrophages had no observable increase under the same conditions 
and were significantly decreased compared to WT cells. The impairment in Fancc-/- 
macrophage adhesion was even more apparent when evaluated on LPS-activated 
endothelial cells. WT macrophages exhibited enhanced adhesion to LPS-activated 
endothelial cells at 1 and 2 hour time points compared to untreated endothelial cell 
controls. However, Fancc-/- macrophages had a dramatic reduction in the number of 
adherent cells at both time points compared to WT cells (Figure 22A-B). Taken together 
these data indicate that Fancc-/- macrophages exhibit impaired adhesion to FN and 
endothelial cells.   
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Figure 22. Fancc-/- macrophages exhibited reduced adhesion on endothelial cells. 
CFSE-labeled peritoneal cells were co-cultured with endothelial cells that had been 
treated with or without LPS. (A) Adhesion on endothelial cells. Representative 
photographs demonstrate the accumulation of peritoneal cells on untreated and LPS 
treated endothelial cells. Photomicrographs were taken on a Leica fluorescent microscope 
(10X). (B) Quantified levels of adhesion. Three independent experiments were 
performed; *P<0.05 compared to WT cells adhered to untreated endothelial cells for 1 
hour, **P<0.05 compared to WT cells in same conditions. 
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C. Impaired migration of Fancc-/- peritoneal macrophages 
Because alterations in adhesion are highly associated with impaired motility, we 
examined whether Fancc-/- macrophages displayed altered migration. WT and Fancc-/- 
macrophages were subjected to a transwell motility assay with soluble chemoattractants 
(MCP-1 and M-CSF). Within 24 hours of migration, Fancc-/- and WT cells had an 
increase in migrated cells in response to both chemoattractants compared to the media 
control (Figure 23A-B). However, fewer Fancc-/- migrated cells were observed in the 
presence of MCP-1 and M-CSF compared to similar conditions with WT cells (Figure 
23A-B). These data suggest that loss of Fancc impairs M-CSF and MCP-1-induced 
macrophage migration, which is consistent with Fancc-/- myeloid progenitor defects 
detected in the presence of M-CSF (Figure 18). Our previous data showed M-CSF 
induced proliferation was impaired in Fancc-/- BMDM, suggesting potential defects in 
the signaling pathway downstream of M-CSF receptor. These data showing that M-CSF 
induced migration was impaired in Fancc-/- macrophage provides additional evidence 
that signaling pathways downstream of the M-CSF receptor is altered in the absence of 
Fancc. 
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Figure 23. Fancc-/- macrophages exhibited reduced migration. Peritoneal cells from 
mice in the steady state were collected and plated in transwell inserts with a pore size of 8 
μM. Cells were allowed to migrate toward MCP1 (20 ng/mL) or M-CSF (50 ng/mL) in 
the bottom chamber of the transwell for 24 hours. Migrated cells were stained with 
crystal violet for visibility and scored by microcopy. (A) Representative 
photomicrographs of migrated cells are shown. Photomicrographs were taken on a Leica 
microscope (20X). (B) MCP1 and M-CSF induced migration of WT and Fancc-/- cells is 
shown. Three independent experiments were performed; *P<0.05.  
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D. Impaired phagocytosis of Fancc-/- peritoneal macrophages 
1. Phagocytosis of E.coli bioparticles 
As a professional phagocyte, phagocytosis is a critical biologic function that 
macrophages perform for pathogen clearance and for inflammation resolution. Therefore, 
we evaluated whether Fancc-/- macrophages also exhibit impaired phagocytosis assessed 
by the uptake of fluorescent E.coli bioparticles and IgG-coated latex beads. Compared to 
WT macrophages, Fancc-/- macrophages had reduced cells that ingested fluorescent  
E.coli particles after 1 hour of co-culture (Figure 24A-B), implying dysfunctional 
phagocytosis mediated by TLR4.  
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Figure 24. Fancc-/- macrophages exhibited decreased phagocytosis of E.coli 
bioparticles. Peritoneal macrophages were cultured for 24 hours and allowed to uptake 
E.coli particles for1 hour. Phagocytosis was estimated by fluorescent microscopy. 
Photomicrographs were taken on a Leica fluorescent microscope using a uniform 
exposure time for all slides under comparison (40X). Rhodamine phalloidin stains red. 
DAPI stains blue. (A) Up-take of E.coli particles. Representative photomicrographs of 
WT and Fancc-/- macrophages phagocytosing E.coli particles are shown. Arrows 
indicate engulfed fluorescent particles in macrophages. (B) Quantified data for E.coli 
particle uptake are shown. Three independent experiments were performed, *P<0.05.  
81 
 
2. Phagocytosis of IgG latex beads 
The impaired phagocytosis of E.coli suggests TLR4 mediated phagocytosis is 
altered in Fancc-/- macrophages. Macrophages express a variety of pathogen receptors 
which initiate phagocytosis. To examine whether the phagocytosis defect of Fancc-/- 
macrophages was specific to TLR4 ligands or a more global defect, we examined 
whether Fc-γ receptor mediated phagocytosis was altered in Fancc-/- macrophages. To 
address this issue, phagocytosis of IgG-coated latex beads, which mainly signals through 
Fc-γ receptor, was assessed. Macrophages were stained with rhodamine labeled 
phalloidin to visualize intracellular F-actin which encircles ingested beads (Figure 25A). 
Macrophages that ingested one or multiple beads were quantified in WT and Fancc-/- 
macrophages. Although phagocytosis of one bead was normal in Fancc-/- macrophages, 
fewer Fancc-/- macrophages ingested multiple beads compared to WT cells (Figure 25B), 
Together these data indicate that both TLR4 and Fc-γ receptor mediated phagocytosis are 
altered in Fancc-/- macrophages, supporting the possibility that loss of Fancc results in a 
more global defect in phagocytosis. 
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Figure 25. Fancc-/- macrophages exhibited decreased phagocytosis of IgG beads. 
Peritoneal macrophages were cultured for 24 hours and allowed to uptake IgG labeled 
beads for 1 hour. Macrophages were fixed and stained with phalloidin and DAPI. 
Phagocytosis was evaluated by confocal microscopy. Photomicrographs were taken on an 
Olympus FV-1000 MPE fluorescent microscope using a uniform exposure time for all 
slides under comparison (60X). (A) Representative photomicrographs of ingestion of IgG 
labeled beads in WT macrophages are shown. Arrows indicate the beads phagocytosed 
by macrophages. Cells were scored by the number of beads ingested. (B) Quantified data 
for number of IgG beads phagocytosed are shown. Three independent experiments were 
performed, *P<0.05.  
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3. Reduced phagocytosis mediated superoxide production 
Superoxide production is a key event for pathogen clearance that occurs during 
and after phagocytosis. If Fancc-/- macrophages have decreased phagocytosis, we 
speculated that superoxide production would also be reduced. To test this hypothesis, 
Fancc-/- and WT macrophages were evaluated for superoxide production during 
phagocytosis of serum opsonized Zymosan (SOZ) and Zymosan. Macrophages from both 
genotypes showed an immediate increase of superoxide production after treatment with 
SOZ and Zymosan compared with no treatment (Figure 26A-B). However, Fancc-/- 
macrophages had attenuated superoxide production in response to SOZ, with a trend 
towards a decreased response to Zymosan (Figure 26A-B) compared to WT cells. These 
data are consistent with the impaired phagocytic activity of Fancc-/- macrophages in 
response to multiple ligands.  
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Figure 26. Fancc-/- macrophages exhibited reduced superoxide production. 
Peritoneal macrophages were cultured for 24 hours and allowed to uptake SOZ, 
Zymosan, or no treatment for one hour. The production and relative amount of 
superoxide was monitored and determined by a lucigenin chemiluminescence assay. (A) 
Superoxide production after phagocytosis of SOZ is shown. Three independent 
experiments were performed, *P<0.05. (B) Superoxide production after phagocytosis of 
Zymosan is shown. Three independent experiments were performed. 
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E. Dysfunctional cytoskeleton reorganization in Fancc-/- macrophages 
The cellular processes of adhesion, migration, and phagocytosis require complex 
actin cytoskeletal rearrangement to occur (Worthylake and Burridge, 2001; Jones, 2000; 
Worthylake et al., 2001). Thus, we speculated that disrupted actin cytoskeletal 
rearrangement may be the unifying mechanism responsible for the functional 
abnormalities detected in Fancc-/- macrophages. Initially to test this hypothesis, F-actin 
content was assessed by rhodamine labeled phalloidin staining and flow cytometry. 
Fancc-/- resident peritoneal cells and adherent macrophage had no significant changes in 
F-actin content compared to WT cells (Figure 27A-B). Therefore, we questioned whether 
F-actin reorganization was altered in Fancc-/- macrophages. The localization of F-actin 
was evaluated by rhodamine labeled phalloidin staining followed by fluorescence 
microscopy. By one hour of adhesion, WT and Fancc-/- cells were round with F-actin in 
a pericellular distribution (Figure 28A). WT macrophages began to polarize from 6 to 24 
hours and developed multiple protrusions, which were enriched with phalloidin staining 
at 6 hours. However, Fancc-/- macrophages remained predominantly circular in shape. 
By 24 hours, WT cells demonstrated cell spreading with a dramatic elongation. F-actin 
staining displayed a fiber-like staining in WT cells and was primarily located in the 
longitudinal axis. In contrast, Fancc-/- macrophages had fewer protrusions at 24 hours, 
and the phalloidin staining remained pericellular in distribution. Moreover, the fiber-like 
staining of phalloidin was rarely observed in Fancc-/- macrophages. In order to quantitate 
qualitative defects observed in Fancc-/- macrophage elongation, we measured the 
spreading and elongation of peritoneal macrophages on FN as described by others (Yu et 
al., 2005) (Figure 28B). Adherent cells were measured for long axis and short axis by 
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Adobe photoshop. The cells with the ratio of Long/Short axes greater than 1 were defined 
as elongating or polarizing cells. Round cells were defined as having a ratio of 1. Figure 
28C illustrates the percentage of elongated cells within 24 hours. WT cells had a dramatic 
increase in the percentage of elongated cells within 6 hours compared to 1 hour. Over 
90% of WT cells finished cell spreading by 24 hours. In contrast, Fancc-/- cells displayed 
a dramatic reduction in percentage of elongated cells by 6 hours and only half of them 
completed elongation by 24 hours. These data indicate that Fancc-/- macrophages have 
insufficient F-actin cytoskeletal rearrangements induced by FN, which may be the 
underlying mechanism responsible for dysfunctional adhesion, migration, and 
phagocytosis.  
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Figure 27. Fancc-/- peritoneal macrophages exhibited normal F-actin content. Fresh 
peritoneal cells from WT and Fancc-/- mice were stained with rhodamine phalloidin and 
examined by flow cytometry to quantitate F-actin content. (A) Representative histogram 
of rhodamin-phalloidin staining. (B) Mean fluorescence intensity (MFI) of rhodamine-
phalloidin staining. MFI of phalloidin staining is shown. Three independent experiments 
were performed. 
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Figure 28. Fancc-/- peritoneal macrophages exhibited impaired elongation. (A) F-
actin localization in macrophage. Macrophages were adhered to FN and stained with 
rhodamine phalloidin. Representative confocal images are shown. Arrows point to the 
elongated cells with concentrated staining of phalloidin. (B) Long axis (L) and short axis 
(S) were measured by Adobe photoshop. Ratio of L/S =1 defined a round cell. Ratio of 
L/S >1 defined an elongating cell. (C) The percentage of elongating cells on FN is 
shown. Three independent experiments were performed, *P<0.05. 
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F. Impaired activation of RhoA in Fancc-/- macrophages  
A variety of proteins are involved in the regulation of actin cytoskeleton 
reorganization and dynamics. Among them, Rho GTPases, including Rac1, Cdc42 and 
RhoA interact with a spectrum of effectors to control actin cytoskeleton reorganization, 
cell shape, and cell polarity (Wheeler and Ridley, 2007; Kao et al., 1999; Liao et al., 
2003; Munugalavadla et al., 2005; Okada et al., 2010; Sulahian et al., 2008; Suzuki and 
Umezawa, 2006). Thus, we examined whether Fancc-/- macrophages had impaired 
activation of small GTPases involved in F-actin regulation. Specifically, Rac1, Cdc42 
and RhoA activities were measured in WT and Fancc-/- peritoneal macrophages. GTP-
Rac1 and GTP-Cdc42 increased after serum stimulation by 10 minutes and declined to 
basal levels by 30 minutes with no significant differences between WT and Fancc-/- 
macrophages (Figure 29A). On the other hand, RhoA activation initiated at 30 minutes in 
WT and remained sustained until 90 minutes (Figure 29C-D). However, in Fancc-/- 
macrophage the activation of RhoA was not increased at 30 minutes and significant 
reduction was observed at later time points compared to WT cells. 
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Figure 29. Impaired activation of RhoA was observed in Fancc-/- macrophages. For 
a single small GTPase activation assay, peritoneal cells from 10 mice per genotype were 
pooled. (A) Representative Rac1 and (B) Cdc42 activation assays are shown. GTP-Rac1 
and GTP-Cdc42 were immunoprecipitated with GST-PBD and detected by Rac1 and 
Cdc42 specific antibodies. (C) Representative RhoA activation assay is shown. GTP-
RhoA was immunoprecipitated with GST-RBD and detected by RhoA antibody. (D) 
Quantification of densitometry data is shown. GTP-RhoA was normalized to total RhoA, 
and the relative change was normalized to time 0. Three independent experiments were 
performed,*P<0.005.
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SUMMARY OF AIM2 
Baseline leukocyte distribution in the peritoneum of Fancc-/- mice was normal, 
however numerous functional deficits were elucidated in resident Fancc-/- macrophages, 
including impaired adhesion, migration, phagocytosis, and superoxide production. The 
unifying mechanism responsible for these phenotypes is speculated to be altered F-actin 
reorganization, which is supported by our data showing abnormal elongation of Fancc-/- 
peritoneal macrophages after adhesion to FN and impaired RhoA activation . 
Collectively, these data support the contention that loss of Fancc not only affects 
hematopoietic stem/progenitor cell functions, as previously thought, but also severely 
impairs immune cell function resulting in an altered inflammatory response in vivo. 
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DISCUSSION 
Astute clinical observations have long suggested that FA patients may have 
immune defects (reviewed in Fagerlie SR, 2006). However, FA genetic heterogeneity 
together with leukopenia from evolving BM failure has made formal proof of this 
concept challenging. Limited previous studies in murine models of FA support altered 
immunologic function (Sejas et al., 2007; Zhang et al., 2007; Hadjur and Jirik, 2003; 
Vanderwerf et al., 2009). However, none of these reports included a systematic 
functional evaluation of macrophages, which are an integral cellular component of the 
innate immune system as well as an antigen presenting cell that participates in the 
coordination of acquired immunity. 
 
1. Altered inflammatory response in Fancc-/- mice 
In the current studies, we show that LPS induced recruitment of Fancc-/- 
monocytes/macrophages to an inflamed peritoneum in vivo is significantly reduced. 
Previous studies demonstrated alterations in the response of Fancc-/- cells to toll-like 
receptor ligands such as LPS and R848 (Vanderwerf et al., 2009; Sejas et al., 2007; 
Hadjur and Jirik, 2003). Decreased Fancc-/- monocyte/macrophage recruitment was not 
specific to toll receptor signaling since a similar response was detected after injection of 
sodium periodate, which induces a non-specific, chemical inflammation. The decrease in 
circulating Fancc-/- inflammatory monocytes after LPS injection suggests that impaired 
monocytes mobilization from the BM may be a contributing factor for fewer 
macrophages observed in the local inflammatory site. However, there are other possible 
explanations for the reduced local monocytes/macrophages which have not been tested. 
93 
 
First of all, the protein level of cytokines/chemokines in the inflamed peritoneum cavity 
has not been examined. We have tested the gene expression of cytokines/chemokines in 
the peritoneal cells. Our data showed reduced mRNA production in Fancc-/- cells. 
However, the total protein levels in the peritoneal fluid could be different from mRNA 
expression in peritoneal cells, because other cell types in the peritoneum may contribute 
to the protein levels of cytokines/chemokines (i.e. endothelial, epithelial and T cells). To 
determine the levels of cytokines/chemokines, Multiplex technique could be used with 
LPS injected peritoneal fluid samples. Secondly, the survival of peritoneal 
monocytes/macrophages were not evaluated in our studies. We showed Fancc-/- mice 
exhibited a decreased number of monocytes/macrophages in the later phase of 
inflammation, which could be due to either decreased recruitment from peripheral blood 
or increased apoptosis of monocytes/macrophages. Although we showed that Fancc-/- 
peritoneal neutrophils had decreased apoptosis in the early phase, the survival of 
macrophages was not assessed. A similar method of testing apoptosis of neutrophils 
could be used for determining the monocytes/macrophages survival. Moreover, the 
identification of Fancc-/- macrophage deficits in vitro, including impaired adhesion, 
migration, and phagocytosis, support macrophage autonomous defects in Fancc-/- mice 
that likely participate in the alterations observed in vivo. Collectively, these data provide 
strong evidence for a primary defect in the function of Fancc-/- macrophage. 
Previously, Sejas and colleagues examined Fancc-/- mice for evidence of 
enhanced systemic inflammation after LPS treatment (Sejas et al., 2007). In these studies, 
investigators reported high serum levels of inflammatory cytokines, especially TNF-α, in 
Fancc-/- mice compared to WT after LPS injection. Therefore, our data demonstrating no 
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differences in serum inflammatory cytokines and reduced inflammatory 
cytokine/chemokine expression in peritoneal cells from Fancc-/- mice after LPS was 
initially surprising. However, the overall goal of our studies was to evaluate for 
alterations in the local inflammatory response, not systemic inflammation. Therefore, 
potential explanations for the apparent discrepant results between our studies and 
previous data include type of inflammatory response initiated, type of LPS used, and 
environment that Fancc-/- mice are housed. IP injections are highly reproducible for LPS 
induced inflammatory response studies in mice (Holmgren et al., 2008; Marquez-Velasco 
et al., 2007). However, handling mice for a proper IP injection can be challenging. To 
keep the results consistent, we treated mice with isoflurane which anaesthesizes the mice 
allowing for the proper treatment of LPS injection and avoiding subcutaneous or 
abdominal organs injection which will cause complete different inflammatory responses 
compared to peritoneal cavity injection. Additionally, we also adjusted the LPS dose 
according to mouse body weight in order to have consistent results. Although we use the 
LPS from the pharmaceutical company, the lot number and the potential quality may be 
different from previous studies. Overall, these are the contributors for the difference we 
observed in Fancc-/- mice from previous studies. However, our findings are consistent 
with a more recent study that reported normal LPS induced TNF-α production from 
Fancc-/- splenic macrophages (Vanderwerf et al., 2009). Interestingly, these studies did 
show that Fancc-/- splenic macrophages treated with a TLR8 agonist overproduced TNF-
α, suggesting that TLR8 signaling may be altered. Taken together, these studies 
emphasize that Fancc-/- immune cells do exhibit altered functions including higher levels 
of TNF-α. Yet, the mechanisms involved needs to be further investigated. 
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2. Impaired adhesion, migration and phagocytosis of Fancc-/- macrophages  
The implications of our findings are significant given the central role that 
macrophages have in both innate and acquired immunity. Furthermore, macrophages 
orchestrate the initiation and resolution phases of an acute inflammatory response 
(Cailhier et al., 2005). The severity of local inflammation is dependent on the type of 
pathogen exposure, efficiency of pathogen clearance, and competent resolution of 
inflammation (Cox et al., 1995; Tabas, 2010). Crucial functions of macrophages in these 
processes are to kill pathogens, phagocytose apoptotic neutrophils, and repair tissue 
injury as a result of the inflammation. Therefore, the modest defects in Fancc-/- 
macrophage function may not result in overt immunodeficiency, but rather subtle 
inefficiencies in pathogen clearance and inflammation resolution, resulting in a 
predisposition towards chronic inflammation or a lower threshold for progression to a 
severe systemic inflammatory response. Studies demonstrating increased serum 
inflammatory cytokines in FA patients are consistent with a chronic inflammatory state in 
FA (Stark et al., 1993; Bagnara et al., 1993; Rosselli et al., 1994). In addition, studies 
showing inflammatory cytokine overproduction as well as hypersensitivity to LPS 
induced shock/death are consistent with a lower threshold for progression to a severe 
systemic inflammatory response in FA (Fagerlie and Bagby, 2006; Sejas et al., 2007; 
Zhang et al., 2007; Dufour et al., 2003). In our studies, LPS is the only stimulus that we 
tested for an altered inflammatory response in Fancc-/- mice. Since LPS is only part of 
gram-negative bacteria, the inflammation induced by real pathogen and endotoxin may be 
very different. Therefore, it is necessary to examine whether Fancc-/- mice exhibit 
altered inflammation in response to a bacterial (eg. E.coli ) infection.  
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3. Classical and alternative macrophage activation 
In the acute-phase of inflammation, pro-inflammatory mediators are released 
primarily by PMNs and inflammatory macrophages. Over time, the inflammatory 
response is dampened by resolving macrophages. Consequently, macrophage activation 
can be pro-inflammatory or anti-inflammatory, which is dependent on intrinsic 
macrophage characteristics and extrinsic environmental cues. Dysregulated activation of 
macrophages contributes to local tissue destruction, systemic inflammation, and chronic 
inflammation. Thus, macrophages have an essential role in initiating, instructing, and 
terminating the adaptive immune response. 
Classically activated or M1 macrophages develop in response to concomitant 
stimulation with IFN-γ and microbial products such as LPS (Adams, 1989; Yamazaki et 
al., 2008; Jeannin et al., 2011). Functionally, M1 macrophages secrete significant 
amounts of pro-inflammatory cytokines, such as TNF-α, IL-1β, and IL-12 (Benoit et al., 
2008). In addition, M1 macrophages are characterized by enhanced endocytic functions 
and ability to kill intracellular pathogens, which is mediated by a variety of mechanisms 
including phagocytosis, phagosome acidification, and nitric oxide (NO) synthesis 
(Groesdonk et al., 2006; Raisanen et al., 2005). NO synthesis in macrophages is 
regulated by the balance between inducible NO synthetase (iNOS) and arginase, which 
sequesters NO by competing the same substrate L-Arginine (Colton et al., 2006). Similar 
to M1 cells, M2 or alternatively activated macrophages change cellular morphology and 
secretory pattern after being stimulated by multiple anti-inflammatory regulators such as 
IL-4, IL-13, TGF-β, and IL-10 (Pixley and Stanley, 2004; Martinez et al., 2008). 
Importantly, M-CSF stimulation of macrophages is critical for intact activation towards 
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an M2 phenotype (Kinashi et al., 1991; Yamazaki et al., 2008). M2 macrophages release 
chemokines including CCL17, and CCL18 (Imai et al., 1999). In addition, M2 
macrophages counteract ongoing inflammation by releasing factors such as Ym1, Ym2, 
IL-10, and TGF-β, which also indirectly promotes tissue repair (Raes et al., 2002a; Raes 
et al., 2002b; Stein et al., 1992). 
Interestingly, previous studies in Fancc-/- peritoneal macrophages demonstrated 
increased iNOS expression and NO production in response to LPS and IFN-γ stimulation. 
Though not discussed in the manuscript, these findings suggest that Fancc-/- 
macrophages exhibit increased M1 activation. Our data showing reduced M-CSF induced 
proliferation, ERK and AKT phosphorylation in Fancc-/- macrophages suggest reduced 
M2 activation. Therefore, we hypothesize that Fancc-/- macrophages have increased 
classical activation and reduced alternative activation leading to an altered inflammatory 
response. Future studies to test this hypothesis will be important. 
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4. Association of altered cytoskeleton rearrangement and decreased RhoA activation 
in Fancc-/- macrophages 
Dramatic morphologic differences were identified between Fancc-/- macrophage 
and controls, which are attributed to disrupted actin rearrangement in Fancc-/- 
macrophage. Complex cytoskeletal rearrangements are essential for numerous cellular 
processes to be intact including adhesion, migration, and phagocytosis. Given that the 
functional defects in Fancc-/- macrophage were induced by numerous extracellular 
stimuli (i.e. FN, M-CSF, MCP-1, SOZ, E.coli), we speculate that dysregulation of 
cytoskeletal organization is the underlying mechanism responsible for the functional 
defects in Fancc-/- macrophage in vitro as well as altered trafficking in vivo. The 
recruitment of monocytes/macrophages to local inflammatory sites is dependent on 
dynamic cell shape changes, which promote cell movement from the blood through the 
endothelium into local tissue environments. Several important steps are involved in this 
process with each individual step requiring dynamic changes in the actin cytoskeleton 
(Vicente-Manzanares and Sanchez-Madrid, 2004; Worthylake et al., 2001; Worthylake 
and Burridge, 2001). Reduced adhesion of Fancc-/- monocytes/macrophages to 
endothelial cells as well as decreased motility of macrophages through the endothelium 
will significantly impact mobilization and recruitment.  
A variety of proteins are involved in the complex regulation of the cytoskeleton. 
Among them, Rho GTPases have a central role in controlling actin cytoskeleton 
reorganization, cell shape, contractility, and polarity (Wheeler and Ridley, 2007; Kao et 
al., 1999; Liao et al., 2003; Munugalavadla et al., 2005; Okada et al., 2010; Sulahian et 
al., 2008; Suzuki and Umezawa, 2006). Interestingly, Fancc-/- macrophage had reduced 
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RhoA-GTP, while Rac1-GTP and Cdc42-GTP levels were normal. Consistent with these 
data, macrophages expressing a dominant negative RhoA mutant exhibit reduced 
migration and phagocytosis (Caron and Hall, 1998; Jones et al., 1998). While no previous 
studies have demonstrated alterations in the activation of Rho GTPases in Fancc-/- 
macrophages, a previous study reported decreased cdc42 activity in FA-A Epstein-Barr 
virus (EBV)–transformed lymphoblastoid cell lines. Reduced Cdc42 activity was 
associated with impaired adhesion of Fanca-/- hematopoietic stem/progenitor cells 
(Zhang et al., 2008). In addition, previous data showed granulocyte-colony stimulating 
factor induced mobilization of neutrophils and HSC/progenitors was decreased in FA 
patients and murine models (Croop et al., 2001; Kang et al., 2001; Pulliam et al., 2008; 
Muller and Williams, 2009). Our data together with these previous observations support 
the hypothesis that deregulated cytoskeletal organization may have a more global 
mechanistic role in the FA hematopoietic phenotype. 
 
5. Attenuated M-CSF responsiveness of Fancc-/- myeloid progenitors and 
macrophages 
Interestingly, our studies demonstrate that Fancc-/- mice challenged with LPS 
exhibit reduced expansion of M-CSF responsive progenitors in the BM. However, 
quantification of hematopoietic stem and progenitor cells by multi-parameter flow 
cytometry showed that absolute numbers of LSK, CMP, and GMP in the BM of WT and 
Fancc-/- mice treated with LPS are not different. We speculated that these findings were 
due to altered M-CSF intracellular signaling in myeloid progenitors. While our studies do 
not directly address whether M-CSF signaling is abnormal in Fancc-/- myeloid 
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progenitors, data from BMDM are supportive of this hypothesis. Fewer numbers of 
Fancc-/- BMDM were obtained after 6 days in culture with M-CSF compared to WT. 
Although M-CSF regulates differentiation, survival, and proliferation of BMDM, only 
proliferation was impaired in Fancc-/- cells. Reduced M-CSF induced ERK and AKT 
phosphorylation were observed in Fancc-/- BMDM, which is consistent with the central 
role that these two proteins have in regulating proliferation of BMDM. Taken together 
these data suggest that monocyte/macrophage generation in vivo is altered under 
conditions of stress. To determine whether M-CSF signaling is also impaired in Fancc-/- 
myeloid progenitors, the next set of experiments would require isolation of LSK, CMP, 
and GMP by flow cytometry followed by stimulation with M-CSF and analyzing for 
activation of downstream signaling molecules such as ERK and AKT. 
Additional clinical evidence suggests that FA patients may exhibit impaired 
macrophage function. Skeletal studies of FA patients demonstrate a high prevalence of 
osteopenia (Giri et al., 2007; Brim et al., 2007). Osteoclasts are reduced, and the balance 
of osteoclast to osteoblast function is altered (Brim et al., 2007). However, the potential 
mechanisms have not been elucidated. As specific BM resident macrophages, osteoclasts 
have an important role in bone resorption. M-CSF is required for intact differentiation, 
proliferation and survival of osteoclasts via activation of ERK and AKT (Bradley et al., 
2008; Umeda et al., 1996). Importantly, adhesion of osteoclasts to the bone surface and 
migration along the bone are integral for intact bone remodeling to occur. Reduced 
adhesion, migration, and phagocytosis of Fancc-/- peritoneal macrophages suggests that 
osteoclasts may also have similar defects that disrupt the balance of bone remodeling in 
101 
 
vivo. Taken together, our data may provide a potential mechanism for skeletal defects 
observed in FA, which warrants further investigation. 
 
6. A limitation of our study: the molecular function of FANCC was not evaluated 
A number of groups have shown that FANCC have non-FA binding partners 
indicating that FANCC is involved in signaling pathways independent of DNA repair. 
For instance, Fancc mutant hematopoietic and embryonic fibroblast cells exhibit 
suppressed STAT1 activation in response to IFN-γ stimulation (Fagerlie et al., 2001; 
Pang et al., 2000). These studies also showed that FANCC and STAT1 physically 
interact in cells stimulated with cytokines. In our studies, we observed suppressed ERK 
and AKT activation in response to M-CSF. To determine the actual link of FANCC and 
M-CSF signaling, it is necessary to investigate where these alterations are initially 
observed downstream of M-CSF stimulation. We speculate FANCC serves as a 
chaperone protein to regulate multiple survival, growth, and proliferation pathways, as 
has been previously suggested (Bagby, 2003). 
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FUTURE STUDIES 
Given the data discussed above several future aims become evident. These aims 
are outlined below with a brief rationale and approach comment. 
 
1. To evaluate whether Fancc-/- mice have altered inflammation and immunity to 
bacterial pathogen challenge in vivo 
LPS is an integral component of the outer cell wall membrane of gram-negative 
bacteria. The toxicity of LPS is associated with Lipid A, and LPS immunogenicity is 
associated with the polysaccharide component (Freudenberg et al., 2008). Humans 
injected with purified LPS develop a cytokine cascade in the serum reminiscent of 
bacterial sepsis (Wilson et al., 1997). The early cytokine response (TNF-α, IL-6, and IL-
8) to LPS in humans coincides with the onset of fever and the activation of blood 
neutrophils, monocytes and lymphocytes. Therefore, IP injection of LPS in mice is a 
popular model to investigate the local inflammatory response followed by the recruitment 
of white blood cells. However, an LPS induced inflammatory response is different from 
gram-negative bacteria induced inflammation. For example, the components for antigen 
presentation are not evaluable in the host by pure LPS injection. In addition, bacterial 
pathogen infection significantly challenges the integrity of the immune system, which 
needs to work as a synergistic network to clear pathogens and resolve ongoing 
inflammation. Therefore, challenging Fancc-/- mice with a local gram negative bacterial 
infection would provide a clinically-relevant test to determine whether immunity and 
inflammation resolution were compromised in FA. 
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2. To determine whether the altered function of macrophages is due to the intrinsic 
role of FANCC 
We identified defects in Fancc-/- macrophages in vivo and in vitro. However, 
these findings do not necessarily mean that the dysfunctional phenotypes observed are 
caused by deficient Fancc expression. Rather, altered Fancc-/- macrophage function 
could be secondary to other mutations given the well-established genomic instability of 
Fancc-/- cells. To address this issue, it is essential to restore Fancc expression in Fancc-/- 
macrophages and assess whether functional deficits of Fancc-/- macrophages are rescued. 
The initial approach for these experiments would be to transduce Fancc-/- peritoneal 
macrophage with a bicistronic lentiviral vector encoding recombinant Fancc and 
enhanced green fluorescent protein. Transduced Fancc-/- cells would be green when 
evaluated by fluorescent microscopy and would be examined for correction of adhesion 
and migration defects, including an evaluation of cytoskeletal rearrangement by confocal 
microscopy after adhesion to FN.  
 
3. To assess whether the dysfunctional cell adhesion of Fancc-/- macrophage is 
secondary to deficient RhoA activation 
Our data demonstrated that Fancc-/- macrophages had impaired adhesion on FN, 
altered F-actin distribution, and impaired RhoA activation, suggesting that defective 
RhoA activation is responsible for altered cytoskeletal rearrangement and subsequent 
dysfunctional adhesion. However, these studies did not assess whether the altered 
adhesion of Fancc-/- macrophages is directly mediated through RhoA. To address this 
important point, it will be necessary to restore RhoA function in Fancc-/- macrophage. 
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To accomplish this goal, we propose to transducer Fancc-/- macrophages with a 
bicistronic lentiviral vector encoding a constitutively active RhoA cDNA and enhanced 
green fluorescent protein (Ghiaur et al., 2006; Melendez et al., 2011) followed by an 
assessment of adhesion and cytoskeletal reorganization. If macrophage elongation and 
adhesion to FN of Fancc-/- macrophage are restored to WT levels, we will conclude that 
altered adhesion and cytoskeletal defects are caused by reduced activation of RhoA.  
 
4. To measure whether M-CSF signaling is altered in myeloid progenitors 
We found that M-CSF signaling was altered in Fancc-/- BMDM characterized by 
reduced phosphorylation of ERK and AKT. These data suggest that activation of ERK 
and AKT may be partially responsible for the decreased number of Fancc-/- BMDM in 
response to M-CSF. In addition, our data show that Fancc-/- myeloid progenitors exhibit 
reduced M-CSF responsiveness after immunologic stress in vivo. However, a direct 
evaluation of M-CSF signaling was not conducted in Fancc-/- myeloid progenitors. 
Therefore, it is necessary to assess M-CSF signaling in monocyte/macrophage 
progenitors. These experiments would require sorting CMPs and GMPs by flow 
cytometry from the BM of WT and Fancc-/- mice injected with either LPS or PBS as 
controls. Sorted cells would be stimulated with M-CSF. Then, the phosphorylation status 
of ERK and AKT would be determined by flow cytometry as previously described 
(Arroyo et al., 2010; Stritesky et al., 2011). Additional studies to evaluate whether M-
CSF induced survival and proliferation on CMP and GMP would also be conducted. 
Again, sorted CMP and GMP from the BM of WT and Fancc-/- mice injected with either 
LPS or PBS would be cultured with M-CSF for six days. During this time, proliferation 
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will be examined by thymidine incorporation assays, and survival will be measured using 
a TUNEL assay. 
 
5. To examine whether Fancc-/- macrophages exhibit altered M1 or M2 activation  
As described in the discussion, M-CSF is important for M2 activation (Kinashi et 
al., 1991; Yamazaki et al., 2008; Pixley and Stanley, 2004). Our data showing that 
Fancc-/- BMDM and myeloid progenitors exhibit altered responsiveness to M-CSF 
suggest that M1/M2 activation may be altered in Fancc-/- mice. Therefore, to determine 
whether Fancc-/- macrophages exhibit altered M1 or M2 activation, we would evaluate 
for mRNA markers of M1/M2 activation, ROS/NO production, and arginase activity in 
WT and Fancc-/- macrophages. Additional details are outlined below.  
To assess cytokine profile. Circulating monocytes will be collected by magnetic 
activated cell sorting selection of CD14+ cells from the peripheral blood of WT and 
Fancc-/- mice. These cells will be stimulated with either LPS and IFN-γ or IL-4 and 
TGF-β to induce an M1 and M2 phenotype respectively, as previously described (Benoit 
et al., 2008; Yamazaki et al., 2008). Cytokine profile will be performed by RT-PCR. M1 
cytokines include TNF-α, IL-1β, IL-12, and IL-23. M2 cytokines include IL-10, IL-4, and 
IL-13.  
To evaluate expression of cluster genes for M1 and M2 activation. Emerging data 
demonstrate that M1 and M2 macrophage exhibit distinct gene expression profiles 
(Pixley and Stanley, 2004; Martinez et al., 2008). For example, M1 macrophages highly 
express Cox2 and iNOS as well as inflammatory cytokines while M2 macrophages highly 
express FIZZ1, Ym, MMR, and arginase as well as anti-inflammatory cytokines (Raes et 
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al., 2002a; Raes et al., 2002b; Stein et al., 1992), Using the same cells and RNA from a), 
the gene expression of M1 and M2 markers would be performed by RT-PCR. 
ROS and NO production.ROS and NO production are sensitive measures of M1 
activation (Groesdonk et al., 2006; Raisanen et al., 2005). Production of ROS and NO 
will be assessed using CM-H2DCFDA and DAF-FM fluorescent probes respectively. 
The percentage of cells positive for ROS/NO probes and mean fluorescence intensity 
would be evaluated by flow cytometry. In addition, ROS and NO production within 
macrophages would be determined by confocal microscopy. 
Arginase activity. Increased arginase activity is one of the most important 
characteristics of alternative or M2 activation (Colton et al., 2006; Chang et al., 2001; 
Abdallahi et al., 2001). Arginase activity assay is a functional analysis of arginase, which 
catalyzes the conversion of arginine to orithine and urea.  
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